EP0681847A2 - Infusion pump with dose-rate calculation - Google Patents

Infusion pump with dose-rate calculation Download PDF

Info

Publication number
EP0681847A2
EP0681847A2 EP95105376A EP95105376A EP0681847A2 EP 0681847 A2 EP0681847 A2 EP 0681847A2 EP 95105376 A EP95105376 A EP 95105376A EP 95105376 A EP95105376 A EP 95105376A EP 0681847 A2 EP0681847 A2 EP 0681847A2
Authority
EP
European Patent Office
Prior art keywords
dose
drug
infusion pump
user
input
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95105376A
Other languages
German (de)
French (fr)
Other versions
EP0681847A3 (en
Inventor
Anne C/O Minnesota Mining And Manufact. Falenzer
Stella C/O Minnesota Mining And Manufact. Larson
Peter M. C/O Minnesota Mining And Eisenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GRASEBY MEDICAL INC.
Original Assignee
Minnesota Mining and Manufacturing Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minnesota Mining and Manufacturing Co filed Critical Minnesota Mining and Manufacturing Co
Publication of EP0681847A2 publication Critical patent/EP0681847A2/en
Publication of EP0681847A3 publication Critical patent/EP0681847A3/en
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14212Pumping with an aspiration and an expulsion action
    • A61M5/14224Diaphragm type
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M2005/14208Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program

Definitions

  • the present invention relates to an infusion pump and method for continuously infusing a patient with a drug over a relatively long period of time, and more particularly to an infusion pump and method in which drug dose and rate calculations are performed based on infusion parameters input to the infusion pump by the user.
  • An infusion pump is used to continuously infuse a patient with a particular drug over a relatively long period of time, such as several hours or days.
  • the drug is infused by the pump from a drug supply, such as a disposable plastic bag containing a predetermined volume and concentration of the drug.
  • the duration of the infusion may necessitate periodic replacement of the drug bag.
  • An infusion pump may have a number of modes of operation, including a manual mode in which the user of the pump specifies the drug flow rate at which the pump is to infuse the patient and an automatic mode in which the pump may be programmed by the user to calculate the drug flow rate from a plurality of infusion parameters input by the user.
  • the infusion parameters may be the drug dose and dose mode recommended or prescribed by a doctor, such as milligrams per minute, the concentration of the drug contained in the drug bag, and sometimes the weight of the patient.
  • the manner in which some infusion pumps must be programmed in the automatic mode is relatively complicated and time consuming, which can be especially disadvantageous in emergency situations when fast action is required.
  • Some types of infusion pumps may incorporate a pumping mechanism which may not be able to pump fluids in continuously varying amounts.
  • the pumping mechanism may be able to pump fluid at a plurality of discrete flow rates, the smallest increment of which may be 0.1 milliliters per hour.
  • the calculated infusion rate is typically rounded, for example, to the nearest 0.1 milliliters per hour.
  • the actual drug dose infused to the patient is not exactly equal to the intended drug dose input by the user of the pump, which can be misleading to the user if the actual drug dose is not displayed on the pump.
  • the intended dose is relatively small, the discrepancy between the intended dose and the dose actually administered to the patient can be substantial.
  • the invention is directed to an infusion pump and method of operating an infusion pump in which the user of the infusion pump is prompted to input a number of infusion parameters, which include a dose mode, a drug dose, the amount of drug contained in the drug container connected to the infusion pump, the volume of the drug in the drug container, and the patient weight if required by the dose mode.
  • the infusion pump automatically calculates an infusion rate corresponding to the desired drug dose input by the user and continuously infuses the patient with the drug in accordance with the calculated infusion rate.
  • the invention is directed to a method of operating an infusion pump in which the user of the infusion pump is prompted to input a plurality of infusion parameters into the infusion pump, including an intended dose of a drug to be administered to a patient.
  • the infusion pump then calculates a drug flow or infusion rate based upon the infusion parameters input by the user and rounds the calculated drug flow rate.
  • the infusion pump then calculates an actual drug dose from the rounded drug flow rate and generates a visual display of the actual drug dose. As a result, the user will be able to inspect the actual drug dose administered to the patient to determine how much it varies from the intended dose.
  • Another aspect of the invention allows the infusion pump to be programmed while it is infusing the patient, which is advantageous in emergency circumstances since an initial infusion may be quickly started without the need to program the infusion pump with all the infusion parameters and a more precise infusion can be subsequently programmed while the initial infusion is running.
  • the user of the infusion pump is prompted to input a plurality of infusion parameters including a dose mode and a drug dose, and a drug infusion rate is calculated based upon the infusion parameters. After the infusion rate is calculated, the patient is continuously infused in accordance with the calculated infusion rate over a second time period.
  • the invention is directed to a method of operating an infusion pump which allows the infusion pump to be programmed more quickly and simply by the user.
  • the user is prompted to input a plurality of infusion parameters into the infusion pump, one of which is a dose mode that is selectable from a plurality of dose modes including a first dose mode which is based upon the weight of the patient to be infused and a second dose mode which is not based upon the weight of the patient to be infused.
  • the infusion pump automatically determines whether the user input the first dose mode, which requires the patient weight, or the second dose mode, which does not require the patient weight.
  • the infusion pump then prompts the user for the weight of the patient only if the first dose mode was input by the user.
  • the infusion pump then calculates the drug infusion rate based upon the infusion parameters and continuously infuses the patient based upon the calculated infusion rate.
  • a schematic diagram of an embodiment of an infusion pump 10 in accordance with the invention is shown to include a pump 12 electrically connected to and driven by a pump controller 14.
  • the pump 12 is connected to a fluid container 16, such as a disposable plastic bag, which contains a liquid drug 18.
  • the drug 18, which is supplied to the pump 12 via a fluid line 20, is continuously infused over a relatively long period of time, such as several hours or days for example, into a patient by the pump 12 via a fluid line 22, such as an intravenous line, connected to a catheter or other injection means (not shown) connected to the patient.
  • the pump 12 may be a syringe pump or a volumetric pump of the type disclosed in U.S. Patent No. 4,322,201 to Archibald, the disclosure of which is incorporated herein by reference, but the particular design of the pump 12 is not considered important to the invention.
  • the pump controller 14 includes a microprocessor 30, a random-access memory (RAM) 32, a read-only memory (ROM) 34, and an input/output (I/O) interface 36, all of which are interconnected via a data bus 38 and an address bus 40.
  • the pump controller 14 may include additional hardware components, such as microprocessors, which relate to other functions and features that are not considered to be pertinent to the invention.
  • the infusion of the drug 18 into the patient is controlled in accordance with a number of infusion parameters input to the infusion pump 10 by the user of the pump, who is typically a nurse or physician, through an integrated keypad/display 44 connected to the pump controller 14 via the I/O interface 36.
  • the operation of the infusion pump 10 is controlled by a computer program which is stored in the ROM 34 and run by the microprocessor 30.
  • a diagram of the overall operation of the infusion pump 10 is illustrated in Fig. 2.
  • the overall operation of the infusion pump 10 includes a standard run mode 50 and a standard hold mode 52.
  • the pump 12 causes the patient to be continuously infused with a particular drug flow rate, such as milliliters per hour (ml/hr), which is specified by the user.
  • ml/hr milliliters per hour
  • Use of the standard run mode requires that the user know the particular drug flow rate at which the drug is to be infused. Since the user may know only the dose of the drug to be administered, such as milligrams per hour (mg/hr), and not the corresponding drug flow rate, use of the standard run mode 50 is limited.
  • the user may cause the infusion pump 10 to transition to the standard hold mode 52 by pressing a pushbutton or key on the integrated keypad/display 44, such as a "Hold" key.
  • the infusion pump 10 remains in the standard hold mode 52 until instructed by the user, by pressing another key, such as a "Run” key, to transition back to the standard run mode 50.
  • the infusion pump 10 may generate a warning message as a reminder to the user that the drug infusion to the patient has been interrupted.
  • An options routine 54 may be invoked from either the standard run mode 50 or the standard hold mode 52 to allow the user to cause the infusion pump 10 to operate in a dose-rate run mode 56 via a dose-rate setup routine 58.
  • the infusion pump 10 infuses the patient with a drug flow rate, such as ml/hr, that was calculated by the infusion pump 10 from a number of infusion parameters input by the user during the dose-rate setup routine 58.
  • the dose-rate run mode 56 is advantageous in that the user does not need to know the flow rate to be administered, which is automatically calculated by the infusion pump 10 from the input infusion parameters.
  • the infusion pump 10 may operate in a dose-rate hold mode 60 in which the drug infusion to the patient is temporarily suspended.
  • the user may cause the infusion pump 10 to change between the dose-rate run and hold modes 56, 60 via the "Run" and "Hold” keys described above.
  • the dose-rate hold mode 60 may also be entered from the options 54 via the dose-rate setup routine 58.
  • the dose-rate setup routine 58 is shown in two places in Fig. 2, it should be understood that there is only one such routine.
  • the options routine 54 which may also be invoked from either the dose-rate run mode 56 or the dose-rate hold mode 60, allows the user to cause the infusion pump 10 to operate in additional modes, such as a quick-rate-change mode, a rate-taper mode, and a volume-over-time mode, and to perform certain procedures, such as changing the panel lighting of the keypad/display 44 and performing a battery test. Since these other modes and procedures are not considered pertinent to the invention, they are not described in detail.
  • the infusion pump 10 may perform a dose-change routine 64 or a rate-change routine 66 from either the dose-rate run mode 56 or the dose-rate hold mode 60.
  • the dose-change routine 64 when invoked from the dose-rate run mode 56, allows the user to input a single infusion parameter consisting of a new drug dose, and the infusion pump 10 automatically calculates and displays a new infusion rate based on the new dose, and infuses the patient at the new rate.
  • the dose-change routine 64 changes the dose in the manner described above, but the new infusion rate is not administered to the patient until the infusion pump 10 transitions from the dose-rate hold mode 60 to the dose-rate run mode 56.
  • the rate-change routine 66 when invoked from the dose-rate run mode 56, allows the user to input a single infusion parameter consisting of a new drug infusion rate.
  • the infusion pump 10 then automatically calculates a new drug dose based on the new infusion rate, displays the new drug dose to the user, and infuses the patient at the new infusion rate.
  • the rate-change routine 66 displays the new dose and changes the infusion rate in the manner described above, but the new infusion rate is not administered to the patient until the infusion pump 10 transitions from the dose-rate hold mode 60 to the dose-rate run mode 56.
  • Figs. 3A-3C illustrate a flowchart of the dose-rate setup routine 58 shown schematically in Fig. 2.
  • the previous dose mode and drug dose are displayed on the integrated keypad/display 44.
  • the previous dose mode and dose are stored in the RAM 32, at least a portion of which is nonvolatile due to a battery backup (not shown) so that the infusion parameters stored in the RAM 32 can be retrieved later on, even if the electrical power to the infusion pump 10 was turned off.
  • infusion pump 10 may be preprogrammed with the appropriate infusion parameters, such as before an operation on a patient, so that the infusion pump 10 can be connected to the patient immediately after the operation without the need to program it at that time.
  • the visual representation of the numeric value of the previous dose is cleared from the display 44.
  • the infusion pump 10 is programmed to assume that if the dose mode is changed by the user, the numeric value of the dose to be used will be different than that of the previous dose. Since the infusion pump 10 is programmed to allow the user to input a numeric value displayed on the display 44 by pressing an enter key, without having to key in the multi-digit numeric value, clearing the dose value from the display 44 at step 104 forces the user to type in the new dose value.
  • the infusion pump 10 has eight possible dose modes: 1) micrograms/Kilogram/minute (mcg/kg/min); 2) micrograms/minute (mcg/min); 3) milligrams/minute (mg/min); 4) milligrams/hour (mg/hr); 5) units/hour; 6) milligrams/kilogram/hour (mg/kg/hr); 7) micrograms/kilogram/hour (mcg/kg/hr); and 8) milligrams/ kilogram/minute (mg/kg/min).
  • the dose modes 1), 6), 7) and 8) are based on the weight of the patient; in these dose modes, the first parameter refers to the amount of the drug to be infused for each kilogram of body weight for each time unit specified by the third parameter. In each of the other four dose modes, the amount of the drug specified by the first parameter is infused for each time unit specified by the second parameter.
  • the first dose mode that is displayed on the display 44 for selection by the user is the dose mode that was used most recently. If the user indicates that another dose mode is desired, the other dose modes are displayed on the display 44, one at a time, in order of frequency of use, the first dose mode being the one that is most frequently used and the last dose mode being the one that is least frequently used. The user toggles through the dose modes until the desired mode is displayed.
  • the user inputs the drug dose to be provided to the patient. This may be accomplished in two ways. If the dose mode was not changed, the user may select the numeric dose value displayed (at step 100) to be the desired dose value by pressing a single key, such as a "*" key. If the dose mode was changed from the previous dose mode, then the user inputs the numeric value of the dose in the units corresponding to the dose mode. For example, if the dose mode is mcg/min, the user would input the dose value in micrograms/minute.
  • the routine branches to step 112 where the previous body weight and units, in either pounds or kilograms, are displayed on the display 44.
  • the user may change the body weight units.
  • the user inputs the patient body weight either by pressing an enter key which causes the displayed bodyweight (at step 112) to be input or alternatively, by entering a different body weight.
  • a second portion of the dose-rate setup routine 58 is illustrated in Fig. 3B.
  • the amount of the drug in the container 16 and the fluid volume of the drug in the container 16 are input by the user.
  • the drug amount and the drug fluid volume are normally printed on the container 16, which is typically a plastic bag or a glass bottle.
  • the drug concentration which is determined by dividing the drug amount by the fluid volume, is not usually printed on the container 16. Since the infusion pump 10 does not require the user to input the drug concentration, there is no need for the user to manually calculate the drug concentration.
  • the numeric value of the previous drug amount and the drug units are displayed at step 122.
  • the numeric value of the previous drug amount is cleared from the display 44.
  • the user selects the desired drug amount units, which may be milligrams, grams, micrograms, or units.
  • the user inputs the numeric value of the drug amount in the same units as those selected, such as in milligrams. This can be accomplished in two ways. If the previous drug amount is displayed on the display 44 (and was not cleared during step 126), the user may input this drug amount by pressing a single entry key. If the previous drug amount is not displayed, the user inputs the numeric value of the drug amount.
  • the numeric value of the previous drug volume is displayed on the display 44.
  • the user inputs the drug volume either by accepting the numeric value of the displayed drug volume by pressing an enter key, or if no drug volume is displayed, by entering the drug volume.
  • the drug volume is entered in milliliters.
  • the infusion pump 10 automatically selects the proper dose-to-rate formula, based on the infusion parameters input by the user, to calculate the infusion rate (in ml/hr) that the pump 12 will administer to the patient.
  • the proper dose-to-rate formula is selected based upon: 1) the dose mode input by the user and 2) the units (micrograms, milligrams, grams or units) in which the drug amount was input by the user.
  • the dose-to-rate equations for each dose mode are set forth in Table 1 below.
  • Rate is the infusion rate (in ml/hr) to be delivered to the patient by the pump 12
  • Dose is the drug dose input by the user
  • A is the drug amount input by the user
  • V is the drug volume input by the user (A/V represents the drug concentration)
  • W is the patient's body weight in kilograms, which is either the numeric value input by the user or, if the body weight was input in pounds, was calculated by the infusion pump 10 with the kg/lbs conversion factor.
  • the dose-to-rate equations listed in category a) above are used when the drug amount A was input by the user in milligrams; the category b) dose-to-rate equations are used when the drug amount A was input in micrograms; and the category c) dose-to-rate equations are used when the drug amount A was input in grams.
  • the infusion rate is calculated based on the infusion parameters input by the user.
  • the infusion rate calculated at step 140 may have to be rounded since the flow rates which the pump 12 is capable of delivering may not be continuously variable.
  • the pump 12 may be capable of delivering discrete flow rates which incrementally vary by 0.1 ml/hr. In that case, a flow rate calculated to be 0.105 ml/hr would be rounded to 0.1 ml/hr.
  • One rounding scheme that may be used is to round flow rates in different ways, depending on the magnitude of the flow rate. For flow rates less than 0.1 ml/hr, no rounding is performed. For flow rates between 0.1 ml/hr and 100 ml/hr, a flow rate between xx.x01 and xx.x49 is rounded to xx.x and a flow rate between xx.x50 and xx.x99 is rounded to xx.(x+1). For example, if the calculated flow rate is 23.337 ml/hr, the rate would be rounded to 23.3 ml/hr.
  • a flow rate between xxx.01 and xxx.49 is rounded to xxx. and a flow rate between xxx.50 and xxx.99 is rounded to xxx+1.
  • Other rounding schemes could be used.
  • the program branches to step 144 where the infusion rate is rounded.
  • the infusion pump 10 determines if the rounded infusion rate is valid by checking to determine whether it falls within a predetermined numeric range, which represents the range of flow rates which the pump 12 is capable of delivering to the patient.
  • a predetermined numeric range which represents the range of flow rates which the pump 12 is capable of delivering to the patient.
  • the permissible flow rate range may have a minimum flow rate of 0.1 ml/hr and a maximum flow rate of 999 ml/hr. If the infusion rate does not fall within the permissible range, the infusion rate is not considered to be valid, a message to that effect is displayed on the display 44, and the routine branches back to step 100 where the user may input different infusion parameters to obtain a valid infusion rate.
  • the infusion pump 10 calculates the actual dose from the rounded infusion rate. This is accomplished by first selecting a proper rate-to-dose equation at step 146 to convert the rounded infusion rate back to a corresponding dose, and then calculating the dose in accordance with the selected rate-to-dose equation at step 148. At step 146, the infusion pump 10 automatically selects the proper rate-to-dose equation to calculate the actual dose that will be administered to the patient.
  • the proper rate-to-dose equation is selected based upon: 1) the dose mode selected by the user, and 2) the units (micrograms, milligrams, grams or units) in which the drug amount was entered by the user.
  • the rate-to-dose equations for each dose mode are set forth in Table 2 below.
  • the variables set forth in the above rate-to-dose equations are the same as those set forth in the dose-to-rate equations of Table 1, except that Rate represents the rounded infusion rate determined at step 144 and Dose represents the actual drug dose to be administered to the patient.
  • rate-to-dose equations listed in category a) above are used when the drug amount A was input by the user in milligrams; the category b) rate-to-dose equations are used when the drug amount A was entered in micrograms; and the category c) rate-to-dose equations are used when the drug amount A was input in grams.
  • the infusion pump 10 determines if the dose calculated at step 148 is valid by checking to determine whether it falls within a permissible dose range between a minimum dose and a maximum dose. If the dose does not fall within the permissible range, the dose calculated at step 148 is not considered to be valid, a message to that effect is displayed on the display 44, and the routine branches back to step 100 where the user may input different infusion parameters to obtain a valid dose.
  • step 150 which is the same as step 145 described above and is performed if the infusion rate was not to be rounded as determined at step 142, the infusion pump 10 determines if the infusion rate calculated at step 140 is valid. If it is not, a message to that effect is displayed on the display 44, and the routine branches back to step 100 where the user may input different infusion parameters to obtain a valid infusion rate.
  • the user may decide either to begin the infusion or to review the infusion parameters that were entered by running through the dose-rate setup routine 58 again. In the latter case, the program branches to step 100 (Fig. 3A). If the user elected to start the infusion, at step 154 the dose, the dose mode, and the infusion rate (in ml/hr) are displayed on the display 44. The dose that is displayed is the actual dose calculated at step 148 if the infusion rate was rounded, or the dose input by the user if the infusion rate was not rounded.
  • the set-up routine 58 assumes that the volume of the drug to be infused over the relatively long infusion period is equal to the fluid contents of the drug container 16. This assumption, which can be changed by the user, saves time in programming the pump with the infusion parameters.
  • the pump 12 will begin the infusion to the patient at the infusion rate displayed at step 154 (when the user presses the "Run” key), and the current infusion pump state will be the dose-rate run mode 56.
  • the dose-rate setup routine 58 was invoked through the options routine 54 when the infusion pump 10 was in one of the hold modes 52, 60, after step 154 (Fig. 3C)
  • the pump 12 will not immediately begin infusing at the infusion rate displayed at step 154, and the infusion pump 10 will be in the dose-rate hold mode 60.
  • the user would press the "Run” key, which would cause a transition from the dose-rate hold mode 60 to the dose-rate run mode 56.
  • the set-up routine 58 allows the infusion pump 10 to be programmed in a very quick and efficient manner, particularly when the infusion pump 10 has been programmed once. For example, after the infusion pump 10 has been initially programmed, it can be reprogrammed (assuming the infusion parameters do not change) in accordance with the flowchart of Figs. 3A-3C by making three keystrokes if patient body weight is not used (at steps 108, 130, 136), or by making four keystrokes if patient body weight is used (at steps 108, 118, 130, 136).
  • Fig. 4 is a flowchart of the rate-change routine 66 shown schematically in Fig. 2.
  • the routine begins at step 200 where the user inputs a new infusion rate.
  • the proper rate-to-dose formula is selected from Table 2 in accordance with the current dose mode and the units in which the drug amount was input.
  • the dose corresponding to the new infusion rate is calculated using the rate-to-dose formula selected in step 202, the new infusion rate input at step 200, and the other current infusion parameters (drug amount A, drug volume V and weight W if necessary), which are stored in the nonvolatile RAM 32.
  • the infusion pump 10 determines whether the new dose calculated at step 204 is within a valid dose range having a minimum dose value and a maximum dose value. If the dose is not within the range, the program branches to step 208 where an alarm message is generated and displayed on the display 44 to indicate that the new dose is not valid, and the previous dose is maintained. If the new dose was valid, at step 210 the new dose is displayed on the display 44.
  • the pump 12 will infuse the patient at the new infusion rate (when the user presses the "Run" key). If the new dose was invalid as determined at step 208, the pump 12 will continue to infuse the patient at the previous infusion rate.
  • the pump 12 will not immediately begin infusing (at either the new rate in case the new dose is valid or the previous rate in case the new dose was invalid).
  • the user would press the "Run" key, which would cause a transition from the dose-rate hold mode 60 to the dose-rate run mode 56.
  • Fig. 5 is a flowchart of the dose-change routine 64 shown schematically in Fig. 2.
  • the routine begins at step 220 where the user inputs a new drug dose.
  • the proper dose-to-rate formula is selected from Table 1 in accordance with the current dose mode and the units in which the drug amount was input.
  • the infusion rate corresponding to the new dose value is calculated using the dose-to-rate formula selected in step 222, the new dose value input at step 220, and the other current infusion parameters (drug amount A, drug volume V and weight W if necessary), which are stored in the nonvolatile RAM 32. Since steps 226-238, which round the new infusion rate if necessary and calculate the actual dose to be infused to the patient, are analogous to steps 142-149 of Fig. 3C, the description of such steps is not repeated.
  • the infusion pump 10 determines whether the new infusion rate calculated at step 224 is within a permissible infusion rate range having a minimum infusion rate and a maximum infusion rate. If the infusion rate is not within the range, the program branches to step 242 where an alarm message is generated and displayed on the display 44, the previous infusion rate is maintained, and the original dose is displayed. If the new infusion rate was valid, at step 244 the new infusion rate is displayed on the display 44.
  • the pump 12 will infuse the patient at the new infusion rate corresponding to the new dose (when the user presses the "Run" key). If the new infusion rate was invalid as determined at either of steps 230, 240 or if the dose was invalid as determined at step 238, the pump 12 will continue to infuse the patient at the previous infusion rate.
  • the pump 12 will not immediately begin infusing (at either the new rate if the new rate is valid or the previous rate if the new rate or dose was invalid).
  • the user would press the "Run" key, which would cause a transition from the dose-rate hold mode 60 to the dose-rate run mode 56.

Abstract

An infusion pump (10) and method of operating an infusion pump in which the user of the infusion pump is prompted to input a number of infusion parameters, which include a dose mode, a drug dose, a drug amount, and a drug volume. After the parameters are input by the user, the infusion pump automatically calculates an infusion rate corresponding to the desired drug dose input by the user. The infusion pump, which includes a fluid pump (12), may round the calculated infusion rate to conform it to a flow rate which the fluid pump can deliver. If the infusion rate is rounded, the infusion pump calculates the actual drug dose from the rounded infusion rate and displays the actual dose on a visual display (44) to allow the user of the infusion pump to determine how much the actual dose varies from the intended dose input by the user. After the actual dose is determined, the infusion pump continuously infuses the patient with the drug at the displayed infusion rate.

Description

  • The present invention relates to an infusion pump and method for continuously infusing a patient with a drug over a relatively long period of time, and more particularly to an infusion pump and method in which drug dose and rate calculations are performed based on infusion parameters input to the infusion pump by the user.
  • An infusion pump is used to continuously infuse a patient with a particular drug over a relatively long period of time, such as several hours or days. The drug is infused by the pump from a drug supply, such as a disposable plastic bag containing a predetermined volume and concentration of the drug. The duration of the infusion may necessitate periodic replacement of the drug bag.
  • An infusion pump may have a number of modes of operation, including a manual mode in which the user of the pump specifies the drug flow rate at which the pump is to infuse the patient and an automatic mode in which the pump may be programmed by the user to calculate the drug flow rate from a plurality of infusion parameters input by the user. The infusion parameters may be the drug dose and dose mode recommended or prescribed by a doctor, such as milligrams per minute, the concentration of the drug contained in the drug bag, and sometimes the weight of the patient. The manner in which some infusion pumps must be programmed in the automatic mode is relatively complicated and time consuming, which can be especially disadvantageous in emergency situations when fast action is required.
  • Some types of infusion pumps may incorporate a pumping mechanism which may not be able to pump fluids in continuously varying amounts. For example, the pumping mechanism may be able to pump fluid at a plurality of discrete flow rates, the smallest increment of which may be 0.1 milliliters per hour. Thus, in such a conventional pump where the infusion rate is automatically determined from a plurality of infusion parameters input by the user, the calculated infusion rate is typically rounded, for example, to the nearest 0.1 milliliters per hour. As a result of such rounding, the actual drug dose infused to the patient is not exactly equal to the intended drug dose input by the user of the pump, which can be misleading to the user if the actual drug dose is not displayed on the pump. In some cases where the intended dose is relatively small, the discrepancy between the intended dose and the dose actually administered to the patient can be substantial.
  • The invention is directed to an infusion pump and method of operating an infusion pump in which the user of the infusion pump is prompted to input a number of infusion parameters, which include a dose mode, a drug dose, the amount of drug contained in the drug container connected to the infusion pump, the volume of the drug in the drug container, and the patient weight if required by the dose mode. After the parameters are input by the user, the infusion pump automatically calculates an infusion rate corresponding to the desired drug dose input by the user and continuously infuses the patient with the drug in accordance with the calculated infusion rate. The invention has a number of different aspects and numerous features and advantages.
  • In one aspect, the invention is directed to a method of operating an infusion pump in which the user of the infusion pump is prompted to input a plurality of infusion parameters into the infusion pump, including an intended dose of a drug to be administered to a patient. The infusion pump then calculates a drug flow or infusion rate based upon the infusion parameters input by the user and rounds the calculated drug flow rate. The infusion pump then calculates an actual drug dose from the rounded drug flow rate and generates a visual display of the actual drug dose. As a result, the user will be able to inspect the actual drug dose administered to the patient to determine how much it varies from the intended dose.
  • Another aspect of the invention allows the infusion pump to be programmed while it is infusing the patient, which is advantageous in emergency circumstances since an initial infusion may be quickly started without the need to program the infusion pump with all the infusion parameters and a more precise infusion can be subsequently programmed while the initial infusion is running. In this aspect of the invention, while the patient is being continuously infused with a drug over a first period of time, the user of the infusion pump is prompted to input a plurality of infusion parameters including a dose mode and a drug dose, and a drug infusion rate is calculated based upon the infusion parameters. After the infusion rate is calculated, the patient is continuously infused in accordance with the calculated infusion rate over a second time period.
  • In a further aspect, the invention is directed to a method of operating an infusion pump which allows the infusion pump to be programmed more quickly and simply by the user. In accordance with this method, the user is prompted to input a plurality of infusion parameters into the infusion pump, one of which is a dose mode that is selectable from a plurality of dose modes including a first dose mode which is based upon the weight of the patient to be infused and a second dose mode which is not based upon the weight of the patient to be infused. After the dose mode is input by the user, the infusion pump automatically determines whether the user input the first dose mode, which requires the patient weight, or the second dose mode, which does not require the patient weight. The infusion pump then prompts the user for the weight of the patient only if the first dose mode was input by the user. The infusion pump then calculates the drug infusion rate based upon the infusion parameters and continuously infuses the patient based upon the calculated infusion rate.
  • These and other features and advantages of the invention will be apparent to those of ordinary skill in the art in view of the detailed description of the preferred embodiment, which is made with reference to the drawings, a brief description of which is provided below.
    • Fig. 1 is a schematic diagram of an embodiment of an infusion pump in accordance with the invention;
    • Fig. 2 is a diagram illustrating the overall operation of the infusion pump;
    • Figs. 3A-3C illustrate a flowchart of a dose-rate setup routine that is performed during the operation of the infusion pump;
    • Fig. 4 is a flowchart of a rate-change routine that may be performed during operation of the infusion pump; and
    • Fig. 5 is a flowchart of a dose-change routine that may be performed during operation of the infusion pump.
  • A schematic diagram of an embodiment of an infusion pump 10 in accordance with the invention is shown to include a pump 12 electrically connected to and driven by a pump controller 14. The pump 12 is connected to a fluid container 16, such as a disposable plastic bag, which contains a liquid drug 18. The drug 18, which is supplied to the pump 12 via a fluid line 20, is continuously infused over a relatively long period of time, such as several hours or days for example, into a patient by the pump 12 via a fluid line 22, such as an intravenous line, connected to a catheter or other injection means (not shown) connected to the patient. The pump 12 may be a syringe pump or a volumetric pump of the type disclosed in U.S. Patent No. 4,322,201 to Archibald, the disclosure of which is incorporated herein by reference, but the particular design of the pump 12 is not considered important to the invention.
  • The pump controller 14 includes a microprocessor 30, a random-access memory (RAM) 32, a read-only memory (ROM) 34, and an input/output (I/O) interface 36, all of which are interconnected via a data bus 38 and an address bus 40. The pump controller 14 may include additional hardware components, such as microprocessors, which relate to other functions and features that are not considered to be pertinent to the invention.
  • The infusion of the drug 18 into the patient is controlled in accordance with a number of infusion parameters input to the infusion pump 10 by the user of the pump, who is typically a nurse or physician, through an integrated keypad/display 44 connected to the pump controller 14 via the I/O interface 36.
  • The operation of the infusion pump 10 is controlled by a computer program which is stored in the ROM 34 and run by the microprocessor 30. A diagram of the overall operation of the infusion pump 10 is illustrated in Fig. 2. Referring to Fig. 2, the overall operation of the infusion pump 10 includes a standard run mode 50 and a standard hold mode 52. During the standard run mode 50, the pump 12 causes the patient to be continuously infused with a particular drug flow rate, such as milliliters per hour (ml/hr), which is specified by the user. Use of the standard run mode requires that the user know the particular drug flow rate at which the drug is to be infused. Since the user may know only the dose of the drug to be administered, such as milligrams per hour (mg/hr), and not the corresponding drug flow rate, use of the standard run mode 50 is limited.
  • If the user wishes to temporarily suspend the drug infusion to the patient, the user may cause the infusion pump 10 to transition to the standard hold mode 52 by pressing a pushbutton or key on the integrated keypad/display 44, such as a "Hold" key. The infusion pump 10 remains in the standard hold mode 52 until instructed by the user, by pressing another key, such as a "Run" key, to transition back to the standard run mode 50. While in the standard hold mode 52, the infusion pump 10 may generate a warning message as a reminder to the user that the drug infusion to the patient has been interrupted.
  • An options routine 54 may be invoked from either the standard run mode 50 or the standard hold mode 52 to allow the user to cause the infusion pump 10 to operate in a dose-rate run mode 56 via a dose-rate setup routine 58. In the dose-rate run mode 56, the infusion pump 10 infuses the patient with a drug flow rate, such as ml/hr, that was calculated by the infusion pump 10 from a number of infusion parameters input by the user during the dose-rate setup routine 58. The dose-rate run mode 56 is advantageous in that the user does not need to know the flow rate to be administered, which is automatically calculated by the infusion pump 10 from the input infusion parameters.
  • The infusion pump 10 may operate in a dose-rate hold mode 60 in which the drug infusion to the patient is temporarily suspended. The user may cause the infusion pump 10 to change between the dose-rate run and hold modes 56, 60 via the "Run" and "Hold" keys described above. The dose-rate hold mode 60 may also be entered from the options 54 via the dose-rate setup routine 58. Although the dose-rate setup routine 58 is shown in two places in Fig. 2, it should be understood that there is only one such routine.
  • The options routine 54, which may also be invoked from either the dose-rate run mode 56 or the dose-rate hold mode 60, allows the user to cause the infusion pump 10 to operate in additional modes, such as a quick-rate-change mode, a rate-taper mode, and a volume-over-time mode, and to perform certain procedures, such as changing the panel lighting of the keypad/display 44 and performing a battery test. Since these other modes and procedures are not considered pertinent to the invention, they are not described in detail.
  • The infusion pump 10 may perform a dose-change routine 64 or a rate-change routine 66 from either the dose-rate run mode 56 or the dose-rate hold mode 60. The dose-change routine 64, when invoked from the dose-rate run mode 56, allows the user to input a single infusion parameter consisting of a new drug dose, and the infusion pump 10 automatically calculates and displays a new infusion rate based on the new dose, and infuses the patient at the new rate. When invoked from the dose-rate hold mode 60, the dose-change routine 64 changes the dose in the manner described above, but the new infusion rate is not administered to the patient until the infusion pump 10 transitions from the dose-rate hold mode 60 to the dose-rate run mode 56.
  • The rate-change routine 66, when invoked from the dose-rate run mode 56, allows the user to input a single infusion parameter consisting of a new drug infusion rate. The infusion pump 10 then automatically calculates a new drug dose based on the new infusion rate, displays the new drug dose to the user, and infuses the patient at the new infusion rate. When invoked from the dose-rate hold mode 60, the rate-change routine 66 displays the new dose and changes the infusion rate in the manner described above, but the new infusion rate is not administered to the patient until the infusion pump 10 transitions from the dose-rate hold mode 60 to the dose-rate run mode 56.
  • Figs. 3A-3C illustrate a flowchart of the dose-rate setup routine 58 shown schematically in Fig. 2. Referring to Fig. 3A, at step 100 of the dose-rate setup routine 58, the previous dose mode and drug dose are displayed on the integrated keypad/display 44. The previous dose mode and dose are stored in the RAM 32, at least a portion of which is nonvolatile due to a battery backup (not shown) so that the infusion parameters stored in the RAM 32 can be retrieved later on, even if the electrical power to the infusion pump 10 was turned off.
  • There are a number of situations in which the same infusion parameters as previously input infusion parameters are used. Typically, infusion is provided to a patient over a relatively long period of time, such as several days, during which the contents of a number of drug containers 16 are emptied. Each time a new container 16 is connected, the same infusion parameters are typically used. In another situation, the infusion pump 10 may be preprogrammed with the appropriate infusion parameters, such as before an operation on a patient, so that the infusion pump 10 can be connected to the patient immediately after the operation without the need to program it at that time.
  • At step 102, if the dose mode displayed at step 100 is not the dose mode desired by the user, at step 104 the visual representation of the numeric value of the previous dose, such as mg/kg/min, is cleared from the display 44. The infusion pump 10 is programmed to assume that if the dose mode is changed by the user, the numeric value of the dose to be used will be different than that of the previous dose. Since the infusion pump 10 is programmed to allow the user to input a numeric value displayed on the display 44 by pressing an enter key, without having to key in the multi-digit numeric value, clearing the dose value from the display 44 at step 104 forces the user to type in the new dose value.
  • At step 106, the user may press a key to change the dose mode. The infusion pump 10 has eight possible dose modes:
    1) micrograms/Kilogram/minute (mcg/kg/min); 2) micrograms/minute (mcg/min); 3) milligrams/minute (mg/min); 4) milligrams/hour (mg/hr); 5) units/hour; 6) milligrams/kilogram/hour (mg/kg/hr); 7) micrograms/kilogram/hour (mcg/kg/hr); and 8) milligrams/ kilogram/minute (mg/kg/min). The dose modes 1), 6), 7) and 8) are based on the weight of the patient; in these dose modes, the first parameter refers to the amount of the drug to be infused for each kilogram of body weight for each time unit specified by the third parameter. In each of the other four dose modes, the amount of the drug specified by the first parameter is infused for each time unit specified by the second parameter.
  • The first dose mode that is displayed on the display 44 for selection by the user is the dose mode that was used most recently. If the user indicates that another dose mode is desired, the other dose modes are displayed on the display 44, one at a time, in order of frequency of use, the first dose mode being the one that is most frequently used and the last dose mode being the one that is least frequently used. The user toggles through the dose modes until the desired mode is displayed.
  • At step 108, the user inputs the drug dose to be provided to the patient. This may be accomplished in two ways. If the dose mode was not changed, the user may select the numeric dose value displayed (at step 100) to be the desired dose value by pressing a single key, such as a "*" key. If the dose mode was changed from the previous dose mode, then the user inputs the numeric value of the dose in the units corresponding to the dose mode. For example, if the dose mode is mcg/min, the user would input the dose value in micrograms/minute.
  • At step 110, if the current dose mode is one of the four modes based on patient body weight, the routine branches to step 112 where the previous body weight and units, in either pounds or kilograms, are displayed on the display 44. At step 114, if the body weight units displayed are not the units desired by the user, at step 116 the user may change the body weight units. When the desired body weight units are displayed, at step 118 the user inputs the patient body weight either by pressing an enter key which causes the displayed bodyweight (at step 112) to be input or alternatively, by entering a different body weight.
  • A second portion of the dose-rate setup routine 58 is illustrated in Fig. 3B. During steps 120-136 of Fig. 3B, the amount of the drug in the container 16 and the fluid volume of the drug in the container 16 are input by the user. The drug amount and the drug fluid volume are normally printed on the container 16, which is typically a plastic bag or a glass bottle. The drug concentration, which is determined by dividing the drug amount by the fluid volume, is not usually printed on the container 16. Since the infusion pump 10 does not require the user to input the drug concentration, there is no need for the user to manually calculate the drug concentration.
  • Referring to Fig. 3B, at step 120, if the dose mode was not changed at step 106 (Fig. 3A) from the previous dose mode, the numeric value of the previous drug amount and the drug units, such as milligrams, are displayed at step 122. At step 124, if the drug amount units displayed on the display 44 are not the desired units, at step 126 the numeric value of the previous drug amount (that was displayed at step 122) is cleared from the display 44. At step 128, the user selects the desired drug amount units, which may be milligrams, grams, micrograms, or units.
  • After the desired drug amount units are selected, at step 130 the user inputs the numeric value of the drug amount in the same units as those selected, such as in milligrams. This can be accomplished in two ways. If the previous drug amount is displayed on the display 44 (and was not cleared during step 126), the user may input this drug amount by pressing a single entry key. If the previous drug amount is not displayed, the user inputs the numeric value of the drug amount.
  • At step 132, if neither the dose mode nor the numeric value of the drug amount was changed, at step 134 the numeric value of the previous drug volume is displayed on the display 44. At step 136, the user inputs the drug volume either by accepting the numeric value of the displayed drug volume by pressing an enter key, or if no drug volume is displayed, by entering the drug volume. The drug volume is entered in milliliters.
  • At step 138, the infusion pump 10 automatically selects the proper dose-to-rate formula, based on the infusion parameters input by the user, to calculate the infusion rate (in ml/hr) that the pump 12 will administer to the patient. The proper dose-to-rate formula is selected based upon: 1) the dose mode input by the user and 2) the units (micrograms, milligrams, grams or units) in which the drug amount was input by the user. The dose-to-rate equations for each dose mode are set forth in Table 1 below.
    Figure imgb0001

    In the above dose-to-rate equations, Rate is the infusion rate (in ml/hr) to be delivered to the patient by the pump 12, Dose is the drug dose input by the user, A is the drug amount input by the user, V is the drug volume input by the user (A/V represents the drug concentration), and W is the patient's body weight in kilograms, which is either the numeric value input by the user or, if the body weight was input in pounds, was calculated by the infusion pump 10 with the kg/lbs conversion factor. The dose-to-rate equations listed in category a) above are used when the drug amount A was input by the user in milligrams; the category b) dose-to-rate equations are used when the drug amount A was input in micrograms; and the category c) dose-to-rate equations are used when the drug amount A was input in grams.
  • Referring to Fig. 3C, after the proper dose-to-rate equation is selected, at step 140 the infusion rate is calculated based on the infusion parameters input by the user. The infusion rate calculated at step 140 may have to be rounded since the flow rates which the pump 12 is capable of delivering may not be continuously variable. For example, the pump 12 may be capable of delivering discrete flow rates which incrementally vary by 0.1 ml/hr. In that case, a flow rate calculated to be 0.105 ml/hr would be rounded to 0.1 ml/hr.
  • One rounding scheme that may be used is to round flow rates in different ways, depending on the magnitude of the flow rate. For flow rates less than 0.1 ml/hr, no rounding is performed. For flow rates between 0.1 ml/hr and 100 ml/hr, a flow rate between xx.x01 and xx.x49 is rounded to xx.x and a flow rate between xx.x50 and xx.x99 is rounded to xx.(x+1). For example, if the calculated flow rate is 23.337 ml/hr, the rate would be rounded to 23.3 ml/hr. For flow rates equal to or greater than 100 ml/hr, a flow rate between xxx.01 and xxx.49 is rounded to xxx. and a flow rate between xxx.50 and xxx.99 is rounded to xxx+1. Other rounding schemes could be used. At step 142, if the infusion rate needs to be rounded, the program branches to step 144 where the infusion rate is rounded.
  • At step 145, the infusion pump 10 determines if the rounded infusion rate is valid by checking to determine whether it falls within a predetermined numeric range, which represents the range of flow rates which the pump 12 is capable of delivering to the patient. For example, the permissible flow rate range may have a minimum flow rate of 0.1 ml/hr and a maximum flow rate of 999 ml/hr. If the infusion rate does not fall within the permissible range, the infusion rate is not considered to be valid, a message to that effect is displayed on the display 44, and the routine branches back to step 100 where the user may input different infusion parameters to obtain a valid infusion rate.
  • If the infusion rate was rounded at step 144, the actual drug dose administered to the patient will not exactly equal the intended dose input by the user. To inform the user of the actual dose to be delivered, the infusion pump 10 calculates the actual dose from the rounded infusion rate. This is accomplished by first selecting a proper rate-to-dose equation at step 146 to convert the rounded infusion rate back to a corresponding dose, and then calculating the dose in accordance with the selected rate-to-dose equation at step 148. At step 146, the infusion pump 10 automatically selects the proper rate-to-dose equation to calculate the actual dose that will be administered to the patient. The proper rate-to-dose equation is selected based upon: 1) the dose mode selected by the user, and 2) the units (micrograms, milligrams, grams or units) in which the drug amount was entered by the user. The rate-to-dose equations for each dose mode are set forth in Table 2 below.
    Figure imgb0002

    The variables set forth in the above rate-to-dose equations are the same as those set forth in the dose-to-rate equations of Table 1, except that Rate represents the rounded infusion rate determined at step 144 and Dose represents the actual drug dose to be administered to the patient. The rate-to-dose equations listed in category a) above are used when the drug amount A was input by the user in milligrams; the category b) rate-to-dose equations are used when the drug amount A was entered in micrograms; and the category c) rate-to-dose equations are used when the drug amount A was input in grams.
  • At step 149, the infusion pump 10 determines if the dose calculated at step 148 is valid by checking to determine whether it falls within a permissible dose range between a minimum dose and a maximum dose. If the dose does not fall within the permissible range, the dose calculated at step 148 is not considered to be valid, a message to that effect is displayed on the display 44, and the routine branches back to step 100 where the user may input different infusion parameters to obtain a valid dose.
  • At step 150, which is the same as step 145 described above and is performed if the infusion rate was not to be rounded as determined at step 142, the infusion pump 10 determines if the infusion rate calculated at step 140 is valid. If it is not, a message to that effect is displayed on the display 44, and the routine branches back to step 100 where the user may input different infusion parameters to obtain a valid infusion rate.
  • At step 152, the user may decide either to begin the infusion or to review the infusion parameters that were entered by running through the dose-rate setup routine 58 again. In the latter case, the program branches to step 100 (Fig. 3A). If the user elected to start the infusion, at step 154 the dose, the dose mode, and the infusion rate (in ml/hr) are displayed on the display 44. The dose that is displayed is the actual dose calculated at step 148 if the infusion rate was rounded, or the dose input by the user if the infusion rate was not rounded.
  • The set-up routine 58 assumes that the volume of the drug to be infused over the relatively long infusion period is equal to the fluid contents of the drug container 16. This assumption, which can be changed by the user, saves time in programming the pump with the infusion parameters.
  • Referring back to Fig. 2, if the dose-rate setup routine 58 was invoked through the options routine 54 when the infusion pump 10 was in one of the run modes 50, 56, after step 154 (Fig. 3C) the pump 12 will begin the infusion to the patient at the infusion rate displayed at step 154 (when the user presses the "Run" key), and the current infusion pump state will be the dose-rate run mode 56. If the dose-rate setup routine 58 was invoked through the options routine 54 when the infusion pump 10 was in one of the hold modes 52, 60, after step 154 (Fig. 3C), the pump 12 will not immediately begin infusing at the infusion rate displayed at step 154, and the infusion pump 10 will be in the dose-rate hold mode 60. To begin infusing at the infusion rate displayed at step 154, the user would press the "Run" key, which would cause a transition from the dose-rate hold mode 60 to the dose-rate run mode 56.
  • It should be appreciated that the set-up routine 58 allows the infusion pump 10 to be programmed in a very quick and efficient manner, particularly when the infusion pump 10 has been programmed once. For example, after the infusion pump 10 has been initially programmed, it can be reprogrammed (assuming the infusion parameters do not change) in accordance with the flowchart of Figs. 3A-3C by making three keystrokes if patient body weight is not used (at steps 108, 130, 136), or by making four keystrokes if patient body weight is used (at steps 108, 118, 130, 136).
  • Fig. 4 is a flowchart of the rate-change routine 66 shown schematically in Fig. 2. Referring to Fig. 4, the routine begins at step 200 where the user inputs a new infusion rate. At step 202, the proper rate-to-dose formula is selected from Table 2 in accordance with the current dose mode and the units in which the drug amount was input. At step 204, the dose corresponding to the new infusion rate is calculated using the rate-to-dose formula selected in step 202, the new infusion rate input at step 200, and the other current infusion parameters (drug amount A, drug volume V and weight W if necessary), which are stored in the nonvolatile RAM 32. At step 206, the infusion pump 10 determines whether the new dose calculated at step 204 is within a valid dose range having a minimum dose value and a maximum dose value. If the dose is not within the range, the program branches to step 208 where an alarm message is generated and displayed on the display 44 to indicate that the new dose is not valid, and the previous dose is maintained. If the new dose was valid, at step 210 the new dose is displayed on the display 44.
  • Referring to Fig. 2, if the rate-change routine 66 was invoked from the dose-rate run mode 56, at the completion of the step 210 (Fig. 4) the pump 12 will infuse the patient at the new infusion rate (when the user presses the "Run" key). If the new dose was invalid as determined at step 208, the pump 12 will continue to infuse the patient at the previous infusion rate.
  • If the rate-change routine 66 was invoked from the dose-rate hold mode 60, the pump 12 will not immediately begin infusing (at either the new rate in case the new dose is valid or the previous rate in case the new dose was invalid). To begin infusing, the user would press the "Run" key, which would cause a transition from the dose-rate hold mode 60 to the dose-rate run mode 56.
  • Fig. 5 is a flowchart of the dose-change routine 64 shown schematically in Fig. 2. Referring to Fig. 5, the routine begins at step 220 where the user inputs a new drug dose. At step 222, the proper dose-to-rate formula is selected from Table 1 in accordance with the current dose mode and the units in which the drug amount was input. At step 224, the infusion rate corresponding to the new dose value is calculated using the dose-to-rate formula selected in step 222, the new dose value input at step 220, and the other current infusion parameters (drug amount A, drug volume V and weight W if necessary), which are stored in the nonvolatile RAM 32. Since steps 226-238, which round the new infusion rate if necessary and calculate the actual dose to be infused to the patient, are analogous to steps 142-149 of Fig. 3C, the description of such steps is not repeated.
  • At step 240, which is performed if the infusion rate was not to be rounded as determined at step 226, the infusion pump 10 determines whether the new infusion rate calculated at step 224 is within a permissible infusion rate range having a minimum infusion rate and a maximum infusion rate. If the infusion rate is not within the range, the program branches to step 242 where an alarm message is generated and displayed on the display 44, the previous infusion rate is maintained, and the original dose is displayed. If the new infusion rate was valid, at step 244 the new infusion rate is displayed on the display 44.
  • Referring to Fig. 2, if the dose-change routine 64 was invoked from the dose-rate run mode 56, at the completion of the step 244 (Fig. 5) the pump 12 will infuse the patient at the new infusion rate corresponding to the new dose (when the user presses the "Run" key). If the new infusion rate was invalid as determined at either of steps 230, 240 or if the dose was invalid as determined at step 238, the pump 12 will continue to infuse the patient at the previous infusion rate.
  • If the dose-change routine 64 was invoked from the dose-rate hold mode 60, the pump 12 will not immediately begin infusing (at either the new rate if the new rate is valid or the previous rate if the new rate or dose was invalid). To begin infusing, the user would press the "Run" key, which would cause a transition from the dose-rate hold mode 60 to the dose-rate run mode 56.
  • Numerous modifications and alternative embodiments of the invention will be apparent to those skilled in the art in view of the foregoing description. This description is to be construed as illustrative only, and is for the purpose of teaching those skilled in the art the best mode of carrying out the invention. The details of the structure and method may be varied substantially without departing from the spirit of the invention, and the exclusive use of all modifications which come within the scope of the appended claims is reserved.

Claims (16)

  1. An infusion pump, comprising:
       means for prompting a user of the infusion pump to input a plurality of infusion parameters into the infusion pump, said plurality of infusion parameters including an intended drug dose of a drug to be administered to a patient;
       means for calculating a drug flow rate based upon said plurality of infusion parameters input by the user;
       means for rounding said drug flow rate calculated by said calculation means to generate a rounded drug flow rate;
       means for calculating an actual drug dose from said rounded drug flow rate, said actual drug dose representing the actual drug dose to be infused to the patient; and
       means for generating a visual display of said actual drug dose to allow the user to compare said actual drug dose with said intended drug dose.
  2. An infusion pump as defined in claim 1 additionally comprising means for continuously infusing the patient with said drug according to said rounded drug flow rate.
  3. An infusion pump as defined in claim 1 or 2 wherein said prompting means comprises:
       means for prompting the user to input a dose mode into the infusion pump;
       means for prompting the user to input a drug amount into the infusion pump; and
       means for prompting the user to input a drug volume into the infusion pump.
  4. An infusion pump as define in claim 3 wherein said prompting means additionally comprises means for prompting the user to input the weight of the patient into the infusion pump.
  5. An infusion pump as defined in any of claims 1 to 4 wherein said prompting means additionally comprises:
       means for prompting the user to input a dose mode being selectable from a plurality of dose modes including a first dose mode being micrograms/kilogram/minute, a second dose mode being micrograms/minute, a third dose mode being milligrams/ minute, and a fourth dose mode being milligrams/hour;
       means for prompting the user to input a drug amount into the infusion pump; and
       means for prompting the user to input a drug volume into the infusion pump.
  6. An infusion pump as defined in any of claims 1 to 5 wherein said prompting means additionally comprises:
       means for prompting the user of the infusion pump to input a dose mode selectable from a plurality of dose modes including a first dose mode which is based upon the weight of the patient to be infused by the infusion pump and a second dose mode which is not based upon the weight of the patient to be infused by the infusion pump;
       means for determing whether the user input said first dose mode to the infusion pump or said second dose mode to the infusion pump; and
       means for prompting the user for the weight of the patient only if the user input said first dose mode.
  7. An infusion pump, comprising:
       means for continuously infusing a patient with a drug over a first period of time;
       means for prompting a user of the infusion pump to input a plurality of infusion parameters into the infusion pump while the patient is being continuously infused with said drug, said prompting means comprising:
       means for prompting the user to input a dose mode; and
       means for prompting the user to input a drug dose after said dose mode is input;
       means for calculating a drug flow rate based upon said plurality of infusion parameters input by the user; and
       means for continuously infusing the patient with said drug over a second period of time based upon said drug flow rate calculated by said calculating means.
  8. An infusion pump as defined in claim 7 wherein said means for continuously infusing the patient comprises means for continuously infusing the patient with said drug over a second period of time based upon said drug flow rate calculated by said calculating means.
  9. An infusion pump as defined in claim 7 or 8 additionally comprising means for rounding said drug flow rate calculated by said calculating means to generate a rounded drug flow rate and wherein said means for continuously infusing the patient comprises means for continuously infusing the patient with said drug over a second period of time based upon said rounded drug flow rate calculated by said rounding means.
  10. An infusion pump as defined in claim 9 additionally comprising:
       means for calculating an actual drug dose from said rounded drug flow rate, said actual drug dose representing the actual drug dose to be infused to the patient; and
       means for generating a visual display of said actual drug dose.
  11. An infusion pump as defined in any of claims 7 to 10 wherein said means for prompting the user to input a dose mode comprises means for prompting the user to input a dose mode selectable from a plurality of dose modes including a first dose mode being micrograms/kilogram/minute, a second dose mode being micrograms/minute, a third dose mode being milligrams/minute, and a fourth dose mode being milligrams/hour, said prompting means additionally comprising:
       means for prompting the user to input a drug amount into the infusion pump; and
       means for prompting the user to input a drug volume into the infusion pump.
  12. An infusion pump as defined in any of claims 7 to 11 wherein said means for prompting the user to input a dose mode comprises means for prompting the user to input a dose mode selectable from a plurality of dose modes including a first dose mode which is based upon the weight of the patient to be infused by the infusion pump and a second dose mode which is not based upon the weight of the patient to be infused by the infusion pump, the infusion pump additionally comprising:
       means for determining whether the user input said first dose mode to the infusion pump or said second dose mode to the infusion pump; and
       means for prompting the user for the weight of the patient only if the user input said first dose mode.
  13. An infusion pump, comprising:
       means for prompting a user of the infusion pump to input a plurality of infusion parameters into the infusion pump, said plurality of infusion parameters including a dose mode being selectable from a plurality of dose modes including a first dose mode which is based upon the weight of a patient to be infused by the infusion pump and a second dose mode which is not based upon the weight of a patient to be infused by the infusion pump;
       means for determining whether the user input said first dose mode to the infusion pump or said second dose mode to the infusion pump;
       means for prompting the user for the weight of the patient only if the user input said first dose mode;
       means for calculating a drug flow rate based upon said plurality of infusion parameters input by the user; and
       means for continuously infusing the patient with said drug over a period of time based upon said drug flow rate calculated by said calculating means.
  14. An infusion pump as defined in claim 13 wherein said means for continuously infusing the patient with said drug comprises means for continuously infusing the patient with said drug from a drug container over a period of time based upon said drug flow rate calculated by said calculating means and wherein said prompting means additionally comprises:
       means for prompting the user to input a drug amount into the infusion pump, said drug amount being the amount of said drug in said drug container; and
       means for prompting the user to input a drug volume into the infusion pump, said drug volume being the fluid volume of said drug in said drug container.
  15. An infusion pump as defined in claim 13 or 14 additionally comprising means for rounding said drug flow rate calculated by said calculating means to generate a rounded drug flow rate and wherein said means for continuously infusing the patient comprises means for continuously infusing the patient with said drug based upon said rounded drug flow rate calculated by said rounding means.
  16. An infusion pump as defined in any of claims 13 to 15 additionally comprising:
       means for calculating an actual drug dose from said rounded drug flow rate, said actual drug dose representing the actual drug dose to be infused to the patient; and
       means for generating a visual display of said actual drug dose.
EP95105376A 1994-04-11 1995-04-10 Infusion pump with dose-rate calculation. Withdrawn EP0681847A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22575394A 1994-04-11 1994-04-11
US225753 1994-04-11

Publications (2)

Publication Number Publication Date
EP0681847A2 true EP0681847A2 (en) 1995-11-15
EP0681847A3 EP0681847A3 (en) 1997-10-15

Family

ID=22846088

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95105376A Withdrawn EP0681847A3 (en) 1994-04-11 1995-04-10 Infusion pump with dose-rate calculation.

Country Status (3)

Country Link
US (1) US5609575A (en)
EP (1) EP0681847A3 (en)
JP (1) JPH07289634A (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997037704A1 (en) * 1996-04-10 1997-10-16 Baxter International Inc. Medical infusion pump
WO2004028596A1 (en) * 2002-09-30 2004-04-08 Novo Nordisk A/S Indicating device with estimating feature
US7967806B2 (en) 2002-10-22 2011-06-28 Medtronic, Inc. Method of delivering a fluid medication to a patient in flex mode
US9677555B2 (en) 2011-12-21 2017-06-13 Deka Products Limited Partnership System, method, and apparatus for infusing fluid
US9675756B2 (en) 2011-12-21 2017-06-13 Deka Products Limited Partnership Apparatus for infusing fluid
CN107126593A (en) * 2017-04-17 2017-09-05 深圳市体太赫兹科技有限公司 The liquid infusion methods and system controlled based on cantilever beam check valve piezoelectricity
US10265463B2 (en) 2014-09-18 2019-04-23 Deka Products Limited Partnership Apparatus and method for infusing fluid through a tube by appropriately heating the tube
US11295846B2 (en) 2011-12-21 2022-04-05 Deka Products Limited Partnership System, method, and apparatus for infusing fluid
US11707615B2 (en) 2018-08-16 2023-07-25 Deka Products Limited Partnership Medical pump

Families Citing this family (272)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5873731A (en) * 1995-10-20 1999-02-23 Eagle Simulation, Inc. Patient drug recognition system
US6689091B2 (en) 1996-08-02 2004-02-10 Tuan Bui Medical apparatus with remote control
US5895371A (en) * 1996-08-27 1999-04-20 Sabratek Corporation Medical treatment apparatus and method
US6605057B2 (en) 1996-10-24 2003-08-12 Medtronic Ave, Inc. Reinforced monorail balloon catheter
US6012034A (en) * 1997-08-18 2000-01-04 Becton, Dickinson And Company System and method for selecting an intravenous device
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
DE19823240A1 (en) 1998-05-25 1999-12-02 Braun Melsungen Ag Device for central control and / or monitoring of infusion pumps
US6554798B1 (en) * 1998-08-18 2003-04-29 Medtronic Minimed, Inc. External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
US6669663B1 (en) * 1999-04-30 2003-12-30 Medtronic, Inc. Closed loop medicament pump
US6355024B1 (en) * 1999-07-14 2002-03-12 Mallinckrodt Inc. Medical fluid delivery system
US6738661B1 (en) 1999-10-22 2004-05-18 Biosynergetics, Inc. Apparatus and methods for the controllable modification of compound concentration in a tube
US6599281B1 (en) * 2000-05-03 2003-07-29 Aspect Medical Systems, Inc. System and method for adaptive drug delivery
JP4681795B2 (en) * 2001-05-18 2011-05-11 デカ・プロダクツ・リミテッド・パートナーシップ Fluid pump infusion set
US8034026B2 (en) * 2001-05-18 2011-10-11 Deka Products Limited Partnership Infusion pump assembly
US6978286B2 (en) * 2001-08-27 2005-12-20 Francis Mathis, Inc. Handheld medication dosage calculator
US7204823B2 (en) * 2001-12-19 2007-04-17 Medtronic Minimed, Inc. Medication delivery system and monitor
US20030125662A1 (en) 2002-01-03 2003-07-03 Tuan Bui Method and apparatus for providing medical treatment therapy based on calculated demand
US10173008B2 (en) 2002-01-29 2019-01-08 Baxter International Inc. System and method for communicating with a dialysis machine through a network
US8775196B2 (en) 2002-01-29 2014-07-08 Baxter International Inc. System and method for notification and escalation of medical data
US8234128B2 (en) 2002-04-30 2012-07-31 Baxter International, Inc. System and method for verifying medical device operational parameters
US7018361B2 (en) * 2002-06-14 2006-03-28 Baxter International Inc. Infusion pump
US7553295B2 (en) 2002-06-17 2009-06-30 Iradimed Corporation Liquid infusion apparatus
US7278983B2 (en) 2002-07-24 2007-10-09 Medtronic Minimed, Inc. Physiological monitoring device for controlling a medication infusion device
US20040068230A1 (en) * 2002-07-24 2004-04-08 Medtronic Minimed, Inc. System for providing blood glucose measurements to an infusion device
US20060129357A1 (en) * 2002-08-27 2006-06-15 Francis Mathis, Inc., D/B/A Informmed Medication dose calculator
US20080052317A1 (en) * 2002-08-27 2008-02-28 Francis Katharine R Medication dose calculator and associated methods
US7427280B2 (en) 2002-09-06 2008-09-23 Medtronic, Inc. Method, system and device for treating disorders of the pelvic floor by delivering drugs to various nerves or tissues
US7328068B2 (en) * 2003-03-31 2008-02-05 Medtronic, Inc. Method, system and device for treating disorders of the pelvic floor by means of electrical stimulation of the pudendal and associated nerves, and the optional delivery of drugs in association therewith
US7276057B2 (en) * 2002-09-06 2007-10-02 Medtronic, Inc. Method, system and device for treating disorders of the pelvic floor by drug delivery to the pudendal and sacral nerves
US7328069B2 (en) * 2002-09-06 2008-02-05 Medtronic, Inc. Method, system and device for treating disorders of the pelvic floor by electrical stimulation of and the delivery of drugs to the left and right pudendal nerves
US7369894B2 (en) * 2002-09-06 2008-05-06 Medtronic, Inc. Method, system and device for treating disorders of the pelvic floor by electrical stimulation of the sacral and/or pudendal nerves
US7381184B2 (en) 2002-11-05 2008-06-03 Abbott Diabetes Care Inc. Sensor inserter assembly
US7811231B2 (en) 2002-12-31 2010-10-12 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US8771183B2 (en) 2004-02-17 2014-07-08 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US7695239B2 (en) * 2003-07-14 2010-04-13 Fortrend Engineering Corporation End effector gripper arms having corner grippers which reorient reticle during transfer
US20190357827A1 (en) 2003-08-01 2019-11-28 Dexcom, Inc. Analyte sensor
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US7299082B2 (en) 2003-10-31 2007-11-20 Abbott Diabetes Care, Inc. Method of calibrating an analyte-measurement device, and associated methods, devices and systems
USD914881S1 (en) 2003-11-05 2021-03-30 Abbott Diabetes Care Inc. Analyte sensor electronic mount
US9757045B2 (en) * 2004-01-27 2017-09-12 Universiteit Gent System and method for adaptive drug delivery
US8467875B2 (en) 2004-02-12 2013-06-18 Medtronic, Inc. Stimulation of dorsal genital nerves to treat urologic dysfunctions
US20060010098A1 (en) 2004-06-04 2006-01-12 Goodnow Timothy T Diabetes care host-client architecture and data management system
US7946984B2 (en) 2004-07-13 2011-05-24 Dexcom, Inc. Transcutaneous analyte sensor
US20060047270A1 (en) * 2004-08-27 2006-03-02 Shelton Brian M Drug delivery apparatus and method for automatically reducing drug dosage
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
US9636450B2 (en) 2007-02-19 2017-05-02 Udo Hoss Pump system modular components for delivering medication and analyte sensing at seperate insertion sites
US20090105569A1 (en) * 2006-04-28 2009-04-23 Abbott Diabetes Care, Inc. Introducer Assembly and Methods of Use
US7731657B2 (en) 2005-08-30 2010-06-08 Abbott Diabetes Care Inc. Analyte sensor introducer and methods of use
US7883464B2 (en) * 2005-09-30 2011-02-08 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US7697967B2 (en) 2005-12-28 2010-04-13 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US9743862B2 (en) 2011-03-31 2017-08-29 Abbott Diabetes Care Inc. Systems and methods for transcutaneously implanting medical devices
US10226207B2 (en) 2004-12-29 2019-03-12 Abbott Diabetes Care Inc. Sensor inserter having introducer
US8333714B2 (en) 2006-09-10 2012-12-18 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US8029441B2 (en) 2006-02-28 2011-10-04 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US9572534B2 (en) 2010-06-29 2017-02-21 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US7896842B2 (en) * 2005-04-11 2011-03-01 Hospira, Inc. System for guiding a user during programming of a medical device
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US20060258985A1 (en) * 2005-05-11 2006-11-16 Russell Claudia J Graphical display of medication limits and delivery program
DE102005028080A1 (en) * 2005-06-17 2006-12-21 Bayer Technology Services Gmbh A method for timed intravenous administration of the anesthetic propofol
US20080314395A1 (en) 2005-08-31 2008-12-25 Theuniversity Of Virginia Patent Foundation Accuracy of Continuous Glucose Sensors
US20090112179A1 (en) * 2005-09-22 2009-04-30 Bart Joseph Zoltan Automated animal dosing system and method
US8852164B2 (en) 2006-02-09 2014-10-07 Deka Products Limited Partnership Method and system for shape-memory alloy wire control
US9521968B2 (en) 2005-09-30 2016-12-20 Abbott Diabetes Care Inc. Analyte sensor retention mechanism and methods of use
US8880138B2 (en) 2005-09-30 2014-11-04 Abbott Diabetes Care Inc. Device for channeling fluid and methods of use
US7766829B2 (en) * 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
EP1968432A4 (en) 2005-12-28 2009-10-21 Abbott Diabetes Care Inc Medical device insertion
US11298058B2 (en) 2005-12-28 2022-04-12 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US7736310B2 (en) 2006-01-30 2010-06-15 Abbott Diabetes Care Inc. On-body medical device securement
US11478623B2 (en) 2006-02-09 2022-10-25 Deka Products Limited Partnership Infusion pump assembly
US11497846B2 (en) 2006-02-09 2022-11-15 Deka Products Limited Partnership Patch-sized fluid delivery systems and methods
US11364335B2 (en) 2006-02-09 2022-06-21 Deka Products Limited Partnership Apparatus, system and method for fluid delivery
DE602007013723D1 (en) * 2006-02-09 2011-05-19 Deka Products Lp SYSTEMS FOR DISPENSING FLUIDS IN PATCH SIZE
US7885698B2 (en) 2006-02-28 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US7826879B2 (en) 2006-02-28 2010-11-02 Abbott Diabetes Care Inc. Analyte sensors and methods of use
US7981034B2 (en) 2006-02-28 2011-07-19 Abbott Diabetes Care Inc. Smart messages and alerts for an infusion delivery and management system
US7630748B2 (en) 2006-10-25 2009-12-08 Abbott Diabetes Care Inc. Method and system for providing analyte monitoring
US8224415B2 (en) 2009-01-29 2012-07-17 Abbott Diabetes Care Inc. Method and device for providing offset model based calibration for analyte sensor
US7653425B2 (en) 2006-08-09 2010-01-26 Abbott Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US9675290B2 (en) 2012-10-30 2017-06-13 Abbott Diabetes Care Inc. Sensitivity calibration of in vivo sensors used to measure analyte concentration
US8473022B2 (en) 2008-01-31 2013-06-25 Abbott Diabetes Care Inc. Analyte sensor with time lag compensation
US7620438B2 (en) 2006-03-31 2009-11-17 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8346335B2 (en) 2008-03-28 2013-01-01 Abbott Diabetes Care Inc. Analyte sensor calibration management
US8140312B2 (en) 2007-05-14 2012-03-20 Abbott Diabetes Care Inc. Method and system for determining analyte levels
US8219173B2 (en) 2008-09-30 2012-07-10 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
US8226891B2 (en) * 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US7618369B2 (en) 2006-10-02 2009-11-17 Abbott Diabetes Care Inc. Method and system for dynamically updating calibration parameters for an analyte sensor
US9392969B2 (en) 2008-08-31 2016-07-19 Abbott Diabetes Care Inc. Closed loop control and signal attenuation detection
US7801582B2 (en) 2006-03-31 2010-09-21 Abbott Diabetes Care Inc. Analyte monitoring and management system and methods therefor
US8374668B1 (en) 2007-10-23 2013-02-12 Abbott Diabetes Care Inc. Analyte sensor with lag compensation
US20070255333A1 (en) * 2006-04-28 2007-11-01 Medtronic, Inc. Neuromodulation therapy for perineal or dorsal branch of pudendal nerve
US7990251B1 (en) 2006-05-17 2011-08-02 Ford Jr Herbert Drug management systems
US8977517B2 (en) * 2006-06-05 2015-03-10 Creighton University System and methods for evaluating efficacy of appetite-affecting drugs
WO2007143225A2 (en) * 2006-06-07 2007-12-13 Abbott Diabetes Care, Inc. Analyte monitoring system and method
US8206296B2 (en) 2006-08-07 2012-06-26 Abbott Diabetes Care Inc. Method and system for providing integrated analyte monitoring and infusion system therapy management
US8932216B2 (en) 2006-08-07 2015-01-13 Abbott Diabetes Care Inc. Method and system for providing data management in integrated analyte monitoring and infusion system
EP2106238A4 (en) 2006-10-26 2011-03-09 Abbott Diabetes Care Inc Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
US8121857B2 (en) 2007-02-15 2012-02-21 Abbott Diabetes Care Inc. Device and method for automatic data acquisition and/or detection
US20080199894A1 (en) 2007-02-15 2008-08-21 Abbott Diabetes Care, Inc. Device and method for automatic data acquisition and/or detection
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
EP2146625B1 (en) 2007-04-14 2019-08-14 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
WO2008128210A1 (en) 2007-04-14 2008-10-23 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in medical communication system
ES2817503T3 (en) 2007-04-14 2021-04-07 Abbott Diabetes Care Inc Procedure and apparatus for providing data processing and control in a medical communication system
CA2683953C (en) 2007-04-14 2016-08-02 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
CA2683959C (en) 2007-04-14 2017-08-29 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
CA2683721C (en) 2007-04-14 2017-05-23 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US8600681B2 (en) 2007-05-14 2013-12-03 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US7996158B2 (en) 2007-05-14 2011-08-09 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8103471B2 (en) 2007-05-14 2012-01-24 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8560038B2 (en) 2007-05-14 2013-10-15 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US9125548B2 (en) 2007-05-14 2015-09-08 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10002233B2 (en) 2007-05-14 2018-06-19 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8444560B2 (en) 2007-05-14 2013-05-21 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8239166B2 (en) 2007-05-14 2012-08-07 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8260558B2 (en) 2007-05-14 2012-09-04 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8617069B2 (en) 2007-06-21 2013-12-31 Abbott Diabetes Care Inc. Health monitor
JP5680960B2 (en) 2007-06-21 2015-03-04 アボット ダイアベティス ケア インコーポレイテッドAbbott Diabetes Care Inc. Health care device and method
US8641618B2 (en) 2007-06-27 2014-02-04 Abbott Diabetes Care Inc. Method and structure for securing a monitoring device element
US8160900B2 (en) 2007-06-29 2012-04-17 Abbott Diabetes Care Inc. Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
US8105282B2 (en) * 2007-07-13 2012-01-31 Iradimed Corporation System and method for communication with an infusion device
US7768386B2 (en) * 2007-07-31 2010-08-03 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8834366B2 (en) 2007-07-31 2014-09-16 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor calibration
US8083503B2 (en) * 2007-09-27 2011-12-27 Curlin Medical Inc. Peristaltic pump assembly and regulator therefor
US7934912B2 (en) * 2007-09-27 2011-05-03 Curlin Medical Inc Peristaltic pump assembly with cassette and mounting pin arrangement
US8062008B2 (en) * 2007-09-27 2011-11-22 Curlin Medical Inc. Peristaltic pump and removable cassette therefor
US8377031B2 (en) 2007-10-23 2013-02-19 Abbott Diabetes Care Inc. Closed loop control system with safety parameters and methods
US8409093B2 (en) 2007-10-23 2013-04-02 Abbott Diabetes Care Inc. Assessing measures of glycemic variability
US8216138B1 (en) 2007-10-23 2012-07-10 Abbott Diabetes Care Inc. Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentration
US7815605B2 (en) 2007-11-28 2010-10-19 Souter Steve R Emergency medication pump injection system
US9026370B2 (en) 2007-12-18 2015-05-05 Hospira, Inc. User interface improvements for medical devices
US20090164239A1 (en) 2007-12-19 2009-06-25 Abbott Diabetes Care, Inc. Dynamic Display Of Glucose Information
US9456955B2 (en) 2007-12-31 2016-10-04 Deka Products Limited Partnership Apparatus, system and method for fluid delivery
US10188787B2 (en) 2007-12-31 2019-01-29 Deka Products Limited Partnership Apparatus, system and method for fluid delivery
WO2009088956A2 (en) 2007-12-31 2009-07-16 Deka Products Limited Partnership Infusion pump assembly
CA2919786C (en) 2007-12-31 2019-10-22 Deka Products Limited Partnership Infusion pump assembly
US8881774B2 (en) 2007-12-31 2014-11-11 Deka Research & Development Corp. Apparatus, system and method for fluid delivery
US8900188B2 (en) 2007-12-31 2014-12-02 Deka Products Limited Partnership Split ring resonator antenna adapted for use in wirelessly controlled medical device
US10080704B2 (en) 2007-12-31 2018-09-25 Deka Products Limited Partnership Apparatus, system and method for fluid delivery
US8252229B2 (en) 2008-04-10 2012-08-28 Abbott Diabetes Care Inc. Method and system for sterilizing an analyte sensor
US8924159B2 (en) 2008-05-30 2014-12-30 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US8591410B2 (en) 2008-05-30 2013-11-26 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US7826382B2 (en) 2008-05-30 2010-11-02 Abbott Diabetes Care Inc. Close proximity communication device and methods
US8057679B2 (en) 2008-07-09 2011-11-15 Baxter International Inc. Dialysis system having trending and alert generation
US10089443B2 (en) 2012-05-15 2018-10-02 Baxter International Inc. Home medical device systems and methods for therapy prescription and tracking, servicing and inventory
WO2010009172A1 (en) 2008-07-14 2010-01-21 Abbott Diabetes Care Inc. Closed loop control system interface and methods
EP2149957B1 (en) * 2008-07-30 2017-06-14 Harman Becker Automotive Systems GmbH Priority based power distribution arrangement
US20100057040A1 (en) 2008-08-31 2010-03-04 Abbott Diabetes Care, Inc. Robust Closed Loop Control And Methods
US8622988B2 (en) 2008-08-31 2014-01-07 Abbott Diabetes Care Inc. Variable rate closed loop control and methods
US9943644B2 (en) 2008-08-31 2018-04-17 Abbott Diabetes Care Inc. Closed loop control with reference measurement and methods thereof
US8734422B2 (en) 2008-08-31 2014-05-27 Abbott Diabetes Care Inc. Closed loop control with improved alarm functions
WO2010031059A2 (en) 2008-09-15 2010-03-18 Deka Products Limited Partnership Systems and methods for fluid delivery
US8986208B2 (en) 2008-09-30 2015-03-24 Abbott Diabetes Care Inc. Analyte sensor sensitivity attenuation mitigation
US8066672B2 (en) 2008-10-10 2011-11-29 Deka Products Limited Partnership Infusion pump assembly with a backup power supply
US8267892B2 (en) 2008-10-10 2012-09-18 Deka Products Limited Partnership Multi-language / multi-processor infusion pump assembly
US8262616B2 (en) * 2008-10-10 2012-09-11 Deka Products Limited Partnership Infusion pump assembly
US8708376B2 (en) 2008-10-10 2014-04-29 Deka Products Limited Partnership Medium connector
US8016789B2 (en) * 2008-10-10 2011-09-13 Deka Products Limited Partnership Pump assembly with a removable cover assembly
US9180245B2 (en) 2008-10-10 2015-11-10 Deka Products Limited Partnership System and method for administering an infusible fluid
US8223028B2 (en) 2008-10-10 2012-07-17 Deka Products Limited Partnership Occlusion detection system and method
US8554579B2 (en) 2008-10-13 2013-10-08 Fht, Inc. Management, reporting and benchmarking of medication preparation
US8105269B2 (en) 2008-10-24 2012-01-31 Baxter International Inc. In situ tubing measurements for infusion pumps
US9326707B2 (en) 2008-11-10 2016-05-03 Abbott Diabetes Care Inc. Alarm characterization for analyte monitoring devices and systems
US20100161346A1 (en) * 2008-12-24 2010-06-24 Kristen Getschmann Systems and Methods for Providing Bolus Dosage Recommendations
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US9402544B2 (en) 2009-02-03 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US8137083B2 (en) 2009-03-11 2012-03-20 Baxter International Inc. Infusion pump actuators, system and method for controlling medical fluid flowrate
US8497777B2 (en) 2009-04-15 2013-07-30 Abbott Diabetes Care Inc. Analyte monitoring system having an alert
WO2010121229A1 (en) 2009-04-16 2010-10-21 Abbott Diabetes Care Inc. Analyte sensor calibration management
US9226701B2 (en) 2009-04-28 2016-01-05 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
US8483967B2 (en) 2009-04-29 2013-07-09 Abbott Diabetes Care Inc. Method and system for providing real time analyte sensor calibration with retrospective backfill
EP2424426B1 (en) 2009-04-29 2020-01-08 Abbott Diabetes Care, Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US9184490B2 (en) 2009-05-29 2015-11-10 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
US8613892B2 (en) 2009-06-30 2013-12-24 Abbott Diabetes Care Inc. Analyte meter with a moveable head and methods of using the same
MX337978B (en) 2009-07-01 2016-03-29 Fresenius Med Care Hldg Inc Drug delivery devices and related systems and methods.
WO2011008966A2 (en) 2009-07-15 2011-01-20 Deka Products Limited Partnership Apparatus, systems and methods for an infusion pump assembly
EP3936032A1 (en) 2009-07-23 2022-01-12 Abbott Diabetes Care, Inc. Real time management of data relating to physiological control of glucose levels
DK3689237T3 (en) 2009-07-23 2021-08-16 Abbott Diabetes Care Inc Method of preparation and system for continuous analyte measurement
WO2011014851A1 (en) 2009-07-31 2011-02-03 Abbott Diabetes Care Inc. Method and apparatus for providing analyte monitoring system calibration accuracy
US9314195B2 (en) 2009-08-31 2016-04-19 Abbott Diabetes Care Inc. Analyte signal processing device and methods
WO2011026148A1 (en) 2009-08-31 2011-03-03 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
ES2912584T3 (en) 2009-08-31 2022-05-26 Abbott Diabetes Care Inc A glucose monitoring system and method
EP3923295A1 (en) 2009-08-31 2021-12-15 Abbott Diabetes Care, Inc. Medical devices and methods
WO2011041469A1 (en) 2009-09-29 2011-04-07 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
WO2011041531A1 (en) 2009-09-30 2011-04-07 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
WO2011053881A1 (en) 2009-10-30 2011-05-05 Abbott Diabetes Care Inc. Method and apparatus for detecting false hypoglycemic conditions
US8382447B2 (en) * 2009-12-31 2013-02-26 Baxter International, Inc. Shuttle pump with controlled geometry
USD924406S1 (en) 2010-02-01 2021-07-06 Abbott Diabetes Care Inc. Analyte sensor inserter
WO2011112753A1 (en) 2010-03-10 2011-09-15 Abbott Diabetes Care Inc. Systems, devices and methods for managing glucose levels
ES2881798T3 (en) 2010-03-24 2021-11-30 Abbott Diabetes Care Inc Medical device inserters and medical device insertion and use procedures
US8635046B2 (en) 2010-06-23 2014-01-21 Abbott Diabetes Care Inc. Method and system for evaluating analyte sensor response characteristics
US11064921B2 (en) 2010-06-29 2021-07-20 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US10092229B2 (en) 2010-06-29 2018-10-09 Abbott Diabetes Care Inc. Calibration of analyte measurement system
US8567235B2 (en) 2010-06-29 2013-10-29 Baxter International Inc. Tube measurement technique using linear actuator and pressure sensor
US11213226B2 (en) 2010-10-07 2022-01-04 Abbott Diabetes Care Inc. Analyte monitoring devices and methods
US10064987B2 (en) 2011-01-31 2018-09-04 Fresenius Medical Care Holdings, Inc. Preventing over-delivery of drug
US9987406B2 (en) 2011-02-08 2018-06-05 Fresenius Medical Care Holdings, Inc. Magnetic sensors and related systems and methods
US10719584B2 (en) * 2011-02-10 2020-07-21 Medtronic, Inc. Medical fluid delivery device programming
US10136845B2 (en) 2011-02-28 2018-11-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
CN103619255B (en) 2011-02-28 2016-11-02 雅培糖尿病护理公司 The device that associates with analyte monitoring device, system and method and combine their device
DK3575796T3 (en) 2011-04-15 2021-01-18 Dexcom Inc ADVANCED ANALYZE SENSOR CALIBRATION AND ERROR DETECTION
EP2727071A4 (en) 2011-07-01 2015-08-12 Baxter Corp Englewood Systems and methods for intelligent patient interface device
US9240002B2 (en) 2011-08-19 2016-01-19 Hospira, Inc. Systems and methods for a graphical interface including a graphical representation of medical data
EP2755717B1 (en) 2011-09-13 2020-07-15 Quest Medical, Inc. Cardioplegia apparatus and method
WO2013066873A1 (en) 2011-10-31 2013-05-10 Abbott Diabetes Care Inc. Electronic devices having integrated reset systems and methods thereof
WO2013066849A1 (en) 2011-10-31 2013-05-10 Abbott Diabetes Care Inc. Model based variable risk false glucose threshold alarm prevention mechanism
US9980669B2 (en) 2011-11-07 2018-05-29 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US9317656B2 (en) 2011-11-23 2016-04-19 Abbott Diabetes Care Inc. Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
US8710993B2 (en) 2011-11-23 2014-04-29 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
WO2013078426A2 (en) 2011-11-25 2013-05-30 Abbott Diabetes Care Inc. Analyte monitoring system and methods of use
FI3300658T3 (en) 2011-12-11 2024-03-01 Abbott Diabetes Care Inc Analyte sensor methods
US10022498B2 (en) 2011-12-16 2018-07-17 Icu Medical, Inc. System for monitoring and delivering medication to a patient and method of using the same to minimize the risks associated with automated therapy
WO2013134519A2 (en) 2012-03-07 2013-09-12 Deka Products Limited Partnership Apparatus, system and method for fluid delivery
ES2741725T3 (en) 2012-03-30 2020-02-12 Icu Medical Inc Air detection system and method to detect air in a pump of an infusion system
US9144646B2 (en) 2012-04-25 2015-09-29 Fresenius Medical Care Holdings, Inc. Vial spiking devices and related assemblies and methods
ES2743160T3 (en) 2012-07-31 2020-02-18 Icu Medical Inc Patient care system for critical medications
EP3395252A1 (en) 2012-08-30 2018-10-31 Abbott Diabetes Care, Inc. Dropout detection in continuous analyte monitoring data during data excursions
US10552577B2 (en) 2012-08-31 2020-02-04 Baxter Corporation Englewood Medication requisition fulfillment system and method
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US9907492B2 (en) 2012-09-26 2018-03-06 Abbott Diabetes Care Inc. Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
SG11201503190RA (en) 2012-10-26 2015-05-28 Baxter Corp Englewood Improved image acquisition for medical dose preparation system
EP2911641B1 (en) 2012-10-26 2018-10-17 Baxter Corporation Englewood Improved work station for medical dose preparation system
EP2948204B1 (en) * 2013-01-28 2021-08-25 Smiths Medical ASD, Inc. Medication safety devices and methods
US10433773B1 (en) 2013-03-15 2019-10-08 Abbott Diabetes Care Inc. Noise rejection methods and apparatus for sparsely sampled analyte sensor data
WO2014152034A1 (en) 2013-03-15 2014-09-25 Abbott Diabetes Care Inc. Sensor fault detection using analyte sensor data pattern comparison
US9474475B1 (en) 2013-03-15 2016-10-25 Abbott Diabetes Care Inc. Multi-rate analyte sensor data collection with sample rate configurable signal processing
AU2014268355B2 (en) 2013-05-24 2018-06-14 Icu Medical, Inc. Multi-sensor infusion system for detecting air or an occlusion in the infusion system
WO2014194065A1 (en) 2013-05-29 2014-12-04 Hospira, Inc. Infusion system and method of use which prevents over-saturation of an analog-to-digital converter
AU2014274146B2 (en) 2013-05-29 2019-01-24 Icu Medical, Inc. Infusion system which utilizes one or more sensors and additional information to make an air determination regarding the infusion system
EP3016629B1 (en) 2013-07-03 2023-12-20 DEKA Products Limited Partnership Apparatus and system for fluid delivery
CA2933166C (en) 2013-12-31 2020-10-27 Abbott Diabetes Care Inc. Self-powered analyte sensor and devices using the same
WO2015114534A1 (en) * 2014-01-28 2015-08-06 Debiotech S.A. Control device with recommendations
JP6636442B2 (en) 2014-02-28 2020-01-29 アイシーユー・メディカル・インコーポレーテッド Infusion systems and methods utilizing dual wavelength optical in-pipe air detection
EP4151150A1 (en) 2014-03-30 2023-03-22 Abbott Diabetes Care, Inc. Method and apparatus for determining meal start and peak events in analyte monitoring systems
JP2017517302A (en) 2014-05-29 2017-06-29 ホスピーラ インコーポレイテッド Infusion system and pump with configurable closed loop delivery rate catchup
EP3161778A4 (en) 2014-06-30 2018-03-14 Baxter Corporation Englewood Managed medical information exchange
US11575673B2 (en) 2014-09-30 2023-02-07 Baxter Corporation Englewood Central user management in a distributed healthcare information management system
US11107574B2 (en) 2014-09-30 2021-08-31 Baxter Corporation Englewood Management of medication preparation with formulary management
WO2016090091A1 (en) 2014-12-05 2016-06-09 Baxter Corporation Englewood Dose preparation data analytics
US11344668B2 (en) 2014-12-19 2022-05-31 Icu Medical, Inc. Infusion system with concurrent TPN/insulin infusion
WO2016102463A1 (en) 2014-12-23 2016-06-30 Bosteels Arnaud Combination of remifentanil and propofol
US10850024B2 (en) 2015-03-02 2020-12-01 Icu Medical, Inc. Infusion system, device, and method having advanced infusion features
EP3265989A4 (en) 2015-03-03 2018-10-24 Baxter Corporation Englewood Pharmacy workflow management with integrated alerts
WO2016183493A1 (en) 2015-05-14 2016-11-17 Abbott Diabetes Care Inc. Compact medical device inserters and related systems and methods
US10213139B2 (en) 2015-05-14 2019-02-26 Abbott Diabetes Care Inc. Systems, devices, and methods for assembling an applicator and sensor control device
CA2985719C (en) 2015-06-25 2024-03-26 Gambro Lundia Ab Medical device system and method having a distributed database
CN107949405A (en) 2015-06-26 2018-04-20 西伊拉塞姆公司 For the Medical Devices and method of temperature adjustment to be carried out to infusion fluid in stent-like structure
WO2017011346A1 (en) 2015-07-10 2017-01-19 Abbott Diabetes Care Inc. System, device and method of dynamic glucose profile response to physiological parameters
EP3377147A1 (en) * 2015-11-18 2018-09-26 Smiths Medical ASD, Inc. Medical infusion pumps and systems
UA126379C2 (en) 2016-04-15 2022-09-28 Баксалта Інкорпорейтед Method and device for providing a pharmacokinetic dosage regimen for medicinal products
EP4085944A1 (en) 2016-05-13 2022-11-09 ICU Medical, Inc. Infusion pump system with common line auto flush
US11324888B2 (en) 2016-06-10 2022-05-10 Icu Medical, Inc. Acoustic flow sensor for continuous medication flow measurements and feedback control of infusion
JPWO2018061560A1 (en) * 2016-09-27 2019-07-04 テルモ株式会社 Drug solution administration apparatus, drug solution administration support system, and drug solution administration support method
WO2018114346A1 (en) 2016-12-21 2018-06-28 Gambro Lundia Ab Medical device system including information technology infrastructure having secure cluster domain supporting external domain
CN110461217B (en) 2017-01-23 2022-09-16 雅培糖尿病护理公司 Systems, devices, and methods for analyte sensor insertion
US10896749B2 (en) 2017-01-27 2021-01-19 Shire Human Genetic Therapies, Inc. Drug monitoring tool
US11596330B2 (en) 2017-03-21 2023-03-07 Abbott Diabetes Care Inc. Methods, devices and system for providing diabetic condition diagnosis and therapy
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
US20190120785A1 (en) 2017-10-24 2019-04-25 Dexcom, Inc. Pre-connected analyte sensors
US11268506B2 (en) 2017-12-22 2022-03-08 Iradimed Corporation Fluid pumps for use in MRI environment
US10089055B1 (en) 2017-12-27 2018-10-02 Icu Medical, Inc. Synchronized display of screen content on networked devices
WO2019209963A1 (en) 2018-04-24 2019-10-31 Deka Products Limited Partnership Apparatus and system for fluid delivery
US11278671B2 (en) 2019-12-04 2022-03-22 Icu Medical, Inc. Infusion pump with safety sequence keypad
CA3189781A1 (en) 2020-07-21 2022-01-27 Icu Medical, Inc. Fluid transfer devices and methods of use
CN111968722A (en) * 2020-08-24 2020-11-20 上海交通大学医学院附属上海儿童医学中心 Vein maintenance medicine information display processing method and system
US11135360B1 (en) 2020-12-07 2021-10-05 Icu Medical, Inc. Concurrent infusion with common line auto flush

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0154191A1 (en) * 1984-02-08 1985-09-11 Abbott Laboratories Infusion system having plural fluid input ports and at least one patient output port
US4898578A (en) * 1988-01-26 1990-02-06 Baxter International Inc. Drug infusion system with calculator
US5104374A (en) * 1990-01-16 1992-04-14 Bishko Jay R Electronic fluid flow rate controller for controlling the infusion of intravenous drugs into a patient
EP0497041A1 (en) * 1991-01-31 1992-08-05 Baxter International Inc. Automated infusion pump with replaceable memory cartridges
WO1994008647A1 (en) * 1992-10-15 1994-04-28 The General Hospital Corporation An infusion pump with an electronically loadable drug library

Family Cites Families (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB369037A (en) * 1931-04-22 1932-03-17 Yoshinobu Wada Improvements in or relating to a pumping apparatus for medical treatments
US3685697A (en) * 1969-01-17 1972-08-22 Lear Siegler Inc Portable infusion pump
US3771694A (en) * 1972-07-07 1973-11-13 A Kaminski Infusion pump
US3990444A (en) * 1972-11-22 1976-11-09 Vial S.A.R.L. Blood transfusion apparatus
US3809871A (en) * 1972-12-01 1974-05-07 Nasa Programmable physiological infusion
US3908652A (en) * 1973-09-10 1975-09-30 Hermann Weissinger Medical infusion apparatus
DE2355966A1 (en) * 1973-11-09 1975-05-22 Medac Klinische Spezialpraep PUMP ARRANGEMENT, ESPECIALLY FOR BLOOD PUMPS
US3901231A (en) * 1974-02-07 1975-08-26 Baxter Laboratories Inc Infusion pump apparatus
US3985133A (en) * 1974-05-28 1976-10-12 Imed Corporation IV pump
US4085747A (en) * 1976-12-13 1978-04-25 Milstein Medical Research Foundation, Inc. Infusion pumps and dosage control means therefor
US4210138A (en) * 1977-12-02 1980-07-01 Baxter Travenol Laboratories, Inc. Metering apparatus for a fluid infusion system with flow control station
DE2758368C2 (en) * 1977-12-28 1985-10-17 Siemens AG, 1000 Berlin und 8000 München Device for the pre-programmable infusion of liquids
US4187057A (en) * 1978-01-11 1980-02-05 Stewart-Naumann Laboratories, Inc. Peristaltic infusion pump and disposable cassette for use therewith
US4256437A (en) * 1978-02-01 1981-03-17 Stewart Naumann Laboratories, Inc. Peristaltic infusion pump and method
DE2826033C2 (en) * 1978-06-14 1982-04-15 Messerschmitt-Bölkow-Blohm GmbH, 8000 München Infusion pump
US4322201A (en) * 1979-03-09 1982-03-30 Avi, Inc. IV Pump with back pressure control
US4731051A (en) * 1979-04-27 1988-03-15 The Johns Hopkins University Programmable control means for providing safe and controlled medication infusion
DE2921066A1 (en) * 1979-05-23 1980-11-27 Siemens Ag ROLL PUMP
US4278085A (en) * 1979-12-13 1981-07-14 Baxter Travenol Laboratories, Inc. Method and apparatus for metered infusion of fluids
DE3015777A1 (en) * 1980-04-24 1981-10-29 Ferring Arzneimittel Gmbh, 2300 Kiel DEVICE FOR INTERMITTENT PULSATORIC APPLICATION OF LIQUID MEDICINAL PRODUCTS
DE3018641C2 (en) * 1980-05-16 1986-05-28 Hans 8228 Freilassing Rodler Automatic infusion pump
DE3114127C2 (en) * 1981-04-08 1984-06-07 Fresenius AG, 6380 Bad Homburg Roll pumps for medical purposes
IL64002A0 (en) * 1981-10-06 1982-01-31 Elmar Medical Systems Ltd Peristaltic pumps
US4529401A (en) * 1982-01-11 1985-07-16 Cardiac Pacemakers, Inc. Ambulatory infusion pump having programmable parameters
US4443218A (en) * 1982-09-09 1984-04-17 Infusaid Corporation Programmable implantable infusate pump
US4519792A (en) * 1982-12-06 1985-05-28 Abbott Laboratories Infusion pump system
US4537561A (en) * 1983-02-24 1985-08-27 Medical Technology, Ltd. Peristaltic infusion pump and disposable cassette for use therewith
US4749109A (en) * 1983-11-15 1988-06-07 Kamen Dean L Volumetric pump with replaceable reservoir assembly
US4685903A (en) * 1984-01-06 1987-08-11 Pacesetter Infusion, Ltd. External infusion pump apparatus
US4741732A (en) * 1984-05-10 1988-05-03 The University Of Melbourne Open-loop control of drug infusion
US4653987A (en) * 1984-07-06 1987-03-31 Tsuyoshi Tsuji Finger peristaltic infusion pump
US4692145A (en) * 1984-10-15 1987-09-08 American Hospital Supply Corporation Power system for infusion pumps
DE3439322A1 (en) * 1984-10-26 1986-05-07 Infors GmbH, 8000 München INFUSION PUMP
DE3442774A1 (en) * 1984-11-20 1986-05-22 "gutta" Gesellschaft für Infusionstechnik mbH, 2000 Hamburg Safety device for infusion-controlling apparatus
US4666430A (en) * 1984-12-05 1987-05-19 I-Flow Corporation Infusion pump
US4756706A (en) * 1985-01-23 1988-07-12 American Hospital Supply Corporation Centrally managed modular infusion pump system
EP0195637A3 (en) * 1985-03-20 1987-08-19 Knight, Robert Leonard Harry An infusion apparatus
US4657490A (en) * 1985-03-27 1987-04-14 Quest Medical, Inc. Infusion pump with disposable cassette
US4840542A (en) * 1985-03-27 1989-06-20 Quest Medical, Inc. Infusion pump with direct pressure sensing
CA1274737A (en) * 1985-08-08 1990-10-02 Joanna Schoon Method and apparatus for automatic profiled infusion in cyclic tpn
US4690673A (en) * 1985-11-26 1987-09-01 Imed Corporation Dual mode I.V. infusion device with distal sensor
US4617014A (en) * 1985-11-26 1986-10-14 Warner-Lambert Company Dual mode I. V. infusion device
US4714462A (en) * 1986-02-03 1987-12-22 Intermedics Infusaid, Inc. Positive pressure programmable infusion pump
US4671792A (en) * 1986-02-18 1987-06-09 American Hospital Supply Corporation Pressure-regulating peristaltic pump
US4689043A (en) * 1986-03-19 1987-08-25 Imed Corporation IV tube activator
US4807170A (en) * 1986-03-25 1989-02-21 John Kulli Drug dose rate calculator
JPH072182B2 (en) * 1986-04-07 1995-01-18 テルモ株式会社 Infusion pump
US4850971A (en) * 1986-05-06 1989-07-25 Triangle Research And Development Corporation Infusion method and means
US4744786A (en) * 1986-06-17 1988-05-17 Cordis Corporation Infusion pump
US4758228A (en) * 1986-11-17 1988-07-19 Centaur Sciences, Inc. Medical infusion pump with sensors
US4856339A (en) * 1986-11-17 1989-08-15 Centaur Sciences, Inc. Medical infusion pump with sensors
US4741736A (en) * 1986-12-10 1988-05-03 I-Flow Corporation Programmable infusion pump
US4808167A (en) * 1987-01-16 1989-02-28 Pacesetter Infusion, Ltd. Medication infusion system with disposable pump/battery cassette
US4725205A (en) * 1987-01-30 1988-02-16 Fisher Scientific Group Inc. Peristaltic pump with cam action compensator
US4728265A (en) * 1987-01-30 1988-03-01 Fisher Scientific Group Inc. Peristaltic pump with cam action compensator
DE3851358D1 (en) * 1987-02-27 1994-10-13 Shimadzu Corp Infusion rate control device.
US4919650A (en) * 1987-03-30 1990-04-24 Bionica Pty. Limited Infusion pump
US4846637A (en) * 1987-04-10 1989-07-11 Alderson Richard K Infusion pump system and conduit therefor
US4890984A (en) * 1987-04-10 1990-01-02 Alderson Richard K Infusion pump system and conduit therefor
US4781548A (en) * 1987-04-10 1988-11-01 Alderson Richard K Infusion pump system and conduit therefor
US4798580A (en) * 1987-04-27 1989-01-17 Site Microsurgical Systems, Inc. Disposable peristaltic pump cassette system
US4976687A (en) * 1987-05-11 1990-12-11 James Martin Apparatus for controlling the supplying of intravenous fluids
AU609843B2 (en) * 1987-06-19 1991-05-09 University Of Melbourne, The Infusion pump
US4838860A (en) * 1987-06-26 1989-06-13 Pump Controller Corporation Infusion pump
US4898579A (en) * 1987-06-26 1990-02-06 Pump Controller Corporation Infusion pump
US4925444A (en) * 1987-08-07 1990-05-15 Baxter Travenol Laboratories, Inc. Closed multi-fluid delivery system and method
US4976696A (en) * 1987-08-10 1990-12-11 Becton, Dickinson And Company Syringe pump and the like for delivering medication
US4850980A (en) * 1987-12-04 1989-07-25 Fisher Scientific Company I.V. pump cassette
US5006997A (en) * 1987-12-15 1991-04-09 Shiley Infusaid, Inc. Pump diagnostic system
US4886431A (en) * 1988-04-29 1989-12-12 Cole-Parmer Instrument Company Peristaltic pump having independently adjustable cartridges
DE3817411A1 (en) * 1988-05-21 1989-11-30 Fresenius Ag MULTIPLE INFUSION SYSTEM
US5131816A (en) * 1988-07-08 1992-07-21 I-Flow Corporation Cartridge fed programmable ambulatory infusion pumps powered by DC electric motors
US4943279A (en) * 1988-09-30 1990-07-24 C. R. Bard, Inc. Medical pump with infusion controlled by a detachable coded label
US5013303A (en) * 1988-11-03 1991-05-07 Yehuda Tamari Constant pressure infusion device
US5006050A (en) * 1988-12-09 1991-04-09 James E. Cooke High accuracy disposable cassette infusion pump
FR2644853B1 (en) * 1989-03-24 1994-03-04 Asulab Sa MINIATURE PERISTALTIC PUMP
US4936760A (en) * 1989-06-12 1990-06-26 Williams David R Volumetric infusion pump
US5061242A (en) * 1989-07-18 1991-10-29 Infusaid, Inc. Adjustable implantable drug infusion system
US4978335A (en) * 1989-09-29 1990-12-18 Medex, Inc. Infusion pump with bar code input to computer
US5018945A (en) * 1989-12-14 1991-05-28 Baxter International Inc. Accurate peristaltic pump
US5116203A (en) * 1990-03-15 1992-05-26 Abbott Laboratories Detecting occlusion of proximal or distal lines of an IV pump
US5256156A (en) * 1991-01-31 1993-10-26 Baxter International Inc. Physician closed-loop neuromuscular blocking agent system
US5256157A (en) * 1991-01-31 1993-10-26 Baxter International Inc. Automated infusion pump with replaceable memory cartridges
US5181910A (en) * 1991-02-28 1993-01-26 Pharmacia Deltec, Inc. Method and apparatus for a fluid infusion system with linearized flow rate change
US5221268A (en) * 1991-12-06 1993-06-22 Block Medical, Inc. Multiple dose control apparatus
US5244463A (en) * 1991-12-06 1993-09-14 Block Medical, Inc. Programmable infusion pump
JPH05277185A (en) * 1992-04-03 1993-10-26 Sharp Corp Infusion device
CA2113905A1 (en) * 1992-05-26 1993-12-09 Baxter International Inc. Infusion pump configuration scheme using eeproms
US5257978A (en) * 1992-07-14 1993-11-02 Habley Medical Technology Corporation IV safety module
US5298021A (en) * 1992-09-24 1994-03-29 Sherer David J ACLS infusion pump system

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0154191A1 (en) * 1984-02-08 1985-09-11 Abbott Laboratories Infusion system having plural fluid input ports and at least one patient output port
US4898578A (en) * 1988-01-26 1990-02-06 Baxter International Inc. Drug infusion system with calculator
US5104374A (en) * 1990-01-16 1992-04-14 Bishko Jay R Electronic fluid flow rate controller for controlling the infusion of intravenous drugs into a patient
EP0497041A1 (en) * 1991-01-31 1992-08-05 Baxter International Inc. Automated infusion pump with replaceable memory cartridges
WO1994008647A1 (en) * 1992-10-15 1994-04-28 The General Hospital Corporation An infusion pump with an electronically loadable drug library

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997037704A1 (en) * 1996-04-10 1997-10-16 Baxter International Inc. Medical infusion pump
US5782805A (en) * 1996-04-10 1998-07-21 Meinzer; Randolph Medical infusion pump
WO2004028596A1 (en) * 2002-09-30 2004-04-08 Novo Nordisk A/S Indicating device with estimating feature
US7967806B2 (en) 2002-10-22 2011-06-28 Medtronic, Inc. Method of delivering a fluid medication to a patient in flex mode
US7967812B2 (en) 2002-10-22 2011-06-28 Medtronic, Inc. Drug infusion system programmable in flex mode
US8480655B2 (en) 2002-10-22 2013-07-09 Medtronic, Inc. Drug infusion system programmable in flex mode
US10288057B2 (en) 2011-12-21 2019-05-14 Deka Products Limited Partnership Peristaltic pump
US11373747B2 (en) 2011-12-21 2022-06-28 Deka Products Limited Partnership Peristaltic pump
US11779703B2 (en) 2011-12-21 2023-10-10 Deka Products Limited Partnership Apparatus for infusing fluid
US10202971B2 (en) 2011-12-21 2019-02-12 Deka Products Limited Partnership Peristaltic pump
US10202970B2 (en) 2011-12-21 2019-02-12 Deka Products Limited Partnership System, method, and apparatus for infusing fluid
US11756662B2 (en) 2011-12-21 2023-09-12 Deka Products Limited Partnership Peristaltic pump
US9677555B2 (en) 2011-12-21 2017-06-13 Deka Products Limited Partnership System, method, and apparatus for infusing fluid
US10316834B2 (en) 2011-12-21 2019-06-11 Deka Products Limited Partnership Peristaltic pump
US10753353B2 (en) 2011-12-21 2020-08-25 Deka Products Limited Partnership Peristaltic pump
US10857293B2 (en) 2011-12-21 2020-12-08 Deka Products Limited Partnership Apparatus for infusing fluid
US11024409B2 (en) 2011-12-21 2021-06-01 Deka Products Limited Partnership Peristaltic pump
US11295846B2 (en) 2011-12-21 2022-04-05 Deka Products Limited Partnership System, method, and apparatus for infusing fluid
US11348674B2 (en) 2011-12-21 2022-05-31 Deka Products Limited Partnership Peristaltic pump
US9675756B2 (en) 2011-12-21 2017-06-13 Deka Products Limited Partnership Apparatus for infusing fluid
US11511038B2 (en) 2011-12-21 2022-11-29 Deka Products Limited Partnership Apparatus for infusing fluid
US11705233B2 (en) 2011-12-21 2023-07-18 Deka Products Limited Partnership Peristaltic pump
US11672903B2 (en) 2014-09-18 2023-06-13 Deka Products Limited Partnership Apparatus and method for infusing fluid through a tube by appropriately heating the tube
US10265463B2 (en) 2014-09-18 2019-04-23 Deka Products Limited Partnership Apparatus and method for infusing fluid through a tube by appropriately heating the tube
CN107126593A (en) * 2017-04-17 2017-09-05 深圳市体太赫兹科技有限公司 The liquid infusion methods and system controlled based on cantilever beam check valve piezoelectricity
US11707615B2 (en) 2018-08-16 2023-07-25 Deka Products Limited Partnership Medical pump

Also Published As

Publication number Publication date
EP0681847A3 (en) 1997-10-15
US5609575A (en) 1997-03-11
JPH07289634A (en) 1995-11-07

Similar Documents

Publication Publication Date Title
US5609575A (en) Infusion pump and method with dose-rate calculation
EP0801578B1 (en) Medicinal fluid pump having multiple stored protocols
EP1109586B2 (en) External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
US5256157A (en) Automated infusion pump with replaceable memory cartridges
JPH05277181A (en) Infusion device
EP0497041A1 (en) Automated infusion pump with replaceable memory cartridges
US6928338B1 (en) Decision information system for drug delivery devices
EP1391215B1 (en) Automated infusion system with dose rate calculator
US20070066956A1 (en) Systems and methods for entering temporary basal rate pattern in an infusion device
US20050137530A1 (en) Infusion device menu structure and method of using the same
US20210316068A1 (en) Infusion pump and infusion pump operations
CA2208791C (en) Medicinal fluid pump having multiple stored protocols

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): DE FR GB IT

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: GRASEBY MEDICAL INC.

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): DE FR GB IT

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19980416